State-Dependent Mapping of GlyR-Cholesterol Interactions by Coupling Crosslinking with Mass Spectrometry by Ferraro, Nicholas
Duquesne University 
Duquesne Scholarship Collection 
Electronic Theses and Dissertations 
Fall 12-20-2019 
State-Dependent Mapping of GlyR-Cholesterol Interactions by 
Coupling Crosslinking with Mass Spectrometry 
Nicholas Ferraro 
Follow this and additional works at: https://dsc.duq.edu/etd 
 Part of the Biochemistry, Biophysics, and Structural Biology Commons 
Recommended Citation 
Ferraro, N. (2019). State-Dependent Mapping of GlyR-Cholesterol Interactions by Coupling Crosslinking 
with Mass Spectrometry (Doctoral dissertation, Duquesne University). Retrieved from 
https://dsc.duq.edu/etd/1837 
This Immediate Access is brought to you for free and open access by Duquesne Scholarship Collection. It has been 
accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of Duquesne 
Scholarship Collection. 
 
 
 
 
STATE-DEPENDENT MAPPING OF GLYR-CHOLESTEROL INTERACTIONS BY 
COUPLING CROSSLINKING WITH MASS SPECTROMETRY 
 
 
 
 
A Dissertation 
Submitted to the Bayer School of Natural and Environmental Science 
 
 
 
Duquesne University 
 
In partial fulfillment of the requirements for 
the degree of Doctor of Philosophy 
 
By 
Nicholas Ferraro 
 
December 2019 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright by 
Nicholas Ferraro 
 
2019 
 iii 
 
 
 
 
 
STATE-DEPENDENT MAPPING OF GLYR-CHOLESTEROL INTERACTIONS BY  
 
COUPLING CROSSLINKING WITH MASS SPECTROMETRY 
 
 
 
 
 
 
 
By 
 
Nicholas Ferraro 
 
Approved November 1, 2019 
 
 
 
 
Michael Cascio 
Associate Professor of Chemistry 
(Committee Chair) 
 
 
Jana Patton-Vogt 
Professor of Biology 
(Committee Member) 
 
 
Philip Reeder 
Dean, Natural and Environmental Sciences 
Professor of Chemistry 
 
Stephanie Wetzel 
Assistant Professor of Chemistry 
(Committee Member) 
 
 
H.M.S. Kingston 
Professor of Chemistry 
(Committee Member) 
 
 
Ellen Gawalt 
Chair, Chemistry and Biochemistry 
Professor of Chemistry 
 
 iv 
 
ABSTRACT 
 
STATE-DEPENDENT MAPPING OF GLYR-CHOLESTEROL INTERACTIONS BY 
COUPLING CROSSLINKING WITH MASS SPECTROMETRY 
 
 
 
By  
Nicholas Ferraro 
December 2019  
 
Dissertation supervised by Michael Cascio 
The glycine receptor (GlyR) belongs to a superfamily of pentameric ligand-gated ion 
channels (pLGICs) that mediate fast neurotransmission. GlyR typically modulates inhibitory 
transmission by antagonizing membrane depolarization through anion influx. Allosteric 
interactions between the receptor and its lipid surroundings affect receptor function, and 
cholesterol is essential for pLGIC activity. Human α1 GlyR was purified from baculovirus infected 
insect cells and reconstituted in unilamellar vesicles at cholesterol: lipid ratios below and above 
the cholesterol activity threshold with aliquots of azi-cholesterol. State-dependent crosslinking 
studies of receptors primarily in its resting (no glycine), desensitized (10mM glycine) and open 
(F207A/A288G, 30nM ivermectin) states were then performed at elevated cholesterol levels 
necessary for activity. After photoactivation, covalently crosslinked cholesterol-GlyR were 
trypsinized, mass fingerprinted by tandem mass spectrometry (MS-MS), and sites of cholesterol 
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crosslinks in peptides were refined by targeted MS-MS. Within the GlyR apo state, cholesterol 
interactions differed as a function of membrane cholesterol concentration correlating to the 
chemical activity of cholesterol, suggesting two distinct conformations.  Differential cholesterol 
crosslinking patterns between resting, desensitized, and open states were observed, highlighting 
state-dependent differences in GlyR lipid accessibility. Distinct state-dependent crosslinking 
patterns indicative of alterations in either the lipid environment and/or channel structure were 
observed throughout GlyR, most prominently observed in the M4 transmembrane helix, 
extracellular domain loops and regions nearing the bilayer interface, and the large intracellular 
M3-M4 loop. The changes in M4 accessibility (transition from surface-mapped crosslinking to 
regions of the helix less exposed when mapped) suggest an outward twisting motion and 
translocation towards the bilayer/lipids as GlyR allosterically transitions. Strikingly, crosslinking 
patterns within the M3-M4 loop offer insight into the generalized structure of this unresolved 
region in all current pLGIC structural models, by suggesting the crosslinked regions of this 
intracellular loop are intimately associated or buried within the lipid bilayer. Taken together, 
crosslinking coupled with MS-MS has the capability to accurately probe and define physiological 
protein frameworks which can aid in the refinement of allosteric modulation and current structural 
models. 
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CHAPTER 1: INTRODUCTION 
 
In order to provide a context for the experimental crosslinking mass spectrometry (CX-MS) 
studies examining the effect of cholesterol concentration on the structure of the resting state of the 
glycine receptor (GlyR)(Chapter 2), and using CX-MS to examine cholesterol-GlyR interactions 
in a state-dependent manner (Chapter 3), the dynamics of membranes as a function of composition, 
GlyR structure and CX-MS methodology are reviewed in this introductory chapter. 
 
1.1     Membrane Dynamics 
 
1.1.1     Lipid Bilayer Properties 
 Lipids are vital bioactive compounds that are a major energy reservoir,1 function as 
chemical messengers in signal transduction2 as well as protein regulation,3 and are critical for 
proper physiological processes.4 Lipids form the structural component of cellular membranes and 
their diversity leads to varying microenvironments of a membrane to accomplish a multitude of 
functions.5 Bilayers spontaneously come together due to the amphiphilic nature of lipids, 
segregating internal cellular components from the outside environment, as the propensity of 
hydrophobic moieties within a lipid to self-associate coupled with the tendency of the hydrophilic 
head groups to interact with other hydrophilic moieties and the aqueous environment.6   
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 In considering phospholipids (Figure 1), there is great diversity in head groups, tail 
lengths, and degrees of saturation resulting in over 100 compounds, and when coupled with the 
multiplicity of other membrane lipids (Figure 1), leads to a wide range of dynamic physical 
properties of cellular membranes.7,8 The lipid’s headgroup (size) and acyl chain (length and 
saturation) composition establish its intrinsic properties (shape, occupational space, interactions) 
which in turn determines side-by-side packing and the shape of each monolayer creating a net 
spontaneous membrane curvature of both inner and outer monolayers.9 Cylindrical lipids such as 
phosphatidylcholine (PC) and phosphatidylserine (PS) promote flat monolayer formation 
compared to the conical shape of phosphatidylethanolamine (PE), phosphatidic acid (PA), 
     
Figure 1. Diagram of general lipids.  (Left) A general schematic of a phospholipid, with the 
hydrophilic region is depicted as consisting of the choline head group, the phosphate linkage, 
and the glycerol backbone. The hydrophobic region is depicted with fatty acid chains of 
saturation (1) and unsaturation (2). (Middle) A general schematic of a sphingolipid, with the 
hydrophilic region depicted as consisting of an amino alcohol linked to a phosphate linked to 
the sphingosine backbone. The sphingosine backbone is linked to a fatty acid creating the 
hydrophobic region.  (Right) A schematic of cholesterol depicting the polar head group region 
linked to the hydrophobic region consisting of a rigid steroid ring structure and hydrocarbon 
tail.62 
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diacylglycerol (DAG), and cardiolipin (headgroups smaller than PC) impose negative curvature of 
head groups being closer together compared to lipids such as lysophosphatidylcholine and 
phosphatidylinositol (larger head group to acyl chain ratio) that promote positive membrane 
curvature bending away from headgroups.10–12 Acyl chain unsaturation (incorporation of double 
bonds) induces kinks in the acyl chain disrupting chain packing which causes each individual lipid 
to occupy more space than saturated acyl chains, thereby making acyl chain saturation along with 
head groups a major factor in the geometry of the membrane, affecting fluidity and melting 
temperatures.9 The incorporation of cis-unsaturation reduces close ordering and side-by-side 
packing which increases membrane permeability.13 Phospholipid head groups play a significant 
role in membrane fluidity and permeability where the strength and relative amount of head group 
intermolecular interactions with the hydrophilic environment can influence relative permeability.14 
Membrane lateral pressure is modulated through head group attraction/repulsion, incorporation of 
sterols or interfacially active solutes, and by acyl chain length and degree and position of chain 
unsaturation.15 Lipid’s influence on cellular function are complex and vary from cell to cell, 
making it difficult to generalize lipid modifications on a given system.8 
 
1.1.2     Cholesterol Characteristics 
 
1.1.2.1     Structural Properties 
 Cholesterol is a major component of nearly all mammalian membranes where its 
heterogeneous distribution among organelles, membranes, and leaflets creates diversity in 
membrane physiochemical properties and function.16 Derived from a sterane backbone, cholesterol 
is a polycyclic amphipathic molecule with a relatively small polar region of a single hydroxyl 
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group linked to a larger apolar section consisting of a four-member ring structure and isooctyl 
chain tail (Figure 1, right).17  The polar hydroxyl “head group” is oriented with the aqueous phase 
and polar head groups of membrane phospholipids and participates as both a hydrogen bond 
acceptor and donor with proximal lipid or protein. This is juxtaposed with the predominant van 
der Waal hydrophobic interactions of the aliphatic groups and aromatic π stacking with lipid acyl 
chains in the hydrophobic region.17,18 The apolar region of cholesterol is asymmetric with two 
distinct faces (α and β), a planar α face and the rough β face defined by the aliphatic methyl groups 
and the isooctyl tail allowing for distinct and preferential interactions with each face.19 These 
properties enable cholesterol interactions with membrane lipids to exhibit bidirectional modulation 
of membrane fluidity, decreasing fluidity of acyl tails above and decreasing fluidity below the gel 
to liquid-crystalline phase transition temperature, respectively.20 Cholesterol reduces the rate of 
motion of phospholipid acyl chains while increasing the degree of  orientation order that leads to 
laterally more condensed membranes with increased phospholipid packing density and decreased 
membrane permeability.20–22 These unique properties of cholesterol allow for the tight regulation 
of a variety of critical cellular functions.23 
 
1.1.2.2     Cholesterol and Microdomains in the Bilayer 
 Cellular bilayers are laterally heterogeneous with distinct sub-populations present in 
leaflets of biological membranes whose distinct interactions drive the association of other lipids 
and proteins.24 Cholesterol is essential for lipid raft formation, a localized highly ordered 
microdomain within a membrane leaflet of higher cholesterol/sphingolipid/saturated phospholipid 
concentration eliciting distinctly less membrane fluidity than the surrounding membrane, where 
cholesterol exhibits a higher affinity to partition in the raft phase than non-raft phase.25,26 These 
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dynamic cholesterol-enriched nanoscale domains are essential for key processes such as membrane 
trafficking, signal transduction, and protein function where the membrane’s heterogeneity is 
critical for specific modulation.27 Proteins partition with lipid rafts at differing degrees and kinetics 
where oligimerization, ligand binding, and modifications such as palmitoylation alter a protein’s 
affinity to partition within the rafts, allowing for precise regulation of raft composition.26 Lipid 
rafts can modulate and respond to protein activation through clustering that concentrates proteins 
and/or provides a protected microenvironment for activation/modification to occur, commonly 
observed in signal transduction pathways.28 Membrane microdomains modulate dopamine 
transporter function where cholesterol-rich membrane fractions promote specific structural 
conformations influencing drug binding.29 The partitioning of the serotonin transporter (SERT) in 
lipid raft microdomains is critical for serotonin uptake activity and dependent on cholesterol 
concentrations.30 Microdomains rich in cholesterol and sphingomyelin modulate several G-protein 
coupled receptor (GPCR) functions including signaling, trafficking, and localization.31 Lipid rafts 
are essential for nicotinic acetylcholine receptor (nAChR) membrane trafficking whereby raft 
disruption alters cell surface exposure and also stabilizes channels in uncoupled conformations.32 
Taken together, microdomains within lipid bilayers and their dynamic compositions are critical for 
the modulation, recruitment, and regulation of membrane proteins.33 
 
1.1.2.3     Activity of Cholesterol 
 A given lipid within a bilayer leaflet exhibits diffusion and partitions into different lateral 
phases according to relative affinity for the phase with the potential to flip leaflets and redistribute 
aqueous region interactions within phases. Therefore, every lipid within the membrane will have 
individual “fugacity” or tendency to partition laterally, distribute transversely, and transfer 
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outwardly between condensed lipid phases of varying order.34 Sterols within lipid complexes can 
exceed the threshold complexing capacity and become dispersed in the bilayer characterized by 
increased escape tendency.35 Cholesterol in molar excess of the capacity of these complexes has 
high fugacity, or termed “active cholesterol”,36 as seen by a abrupt increase in sterol availability to 
cholesterol oxidase,37 perfringolysin,38 and methyl-β-cyclodextrin,39 emerging at concentrations 
above 25-35 mol percent (typical physiological concentrations).40,41 Excess cholesterol exhibits 
high chemical activity in a chemical phase distinct from that observed under negligible chemical 
activity.42 Thus, slight variations in cholesterol concentrations about its typical physiological levels 
has the potential to drive regulatory processes within or on the plasma membrane surface,43 either 
indirectly by modulating plasma membrane physical properties or directly as a protein regulator.20 
Phospholipid acyl tail configuration (cis vs. trans unsaturation) alters cholesterol-phospholipid 
affinity in which trans unsaturation exhibited lower cholesterol activity than cis counterparts.44 
The presence of active cholesterol elicits a variety of feedback response mechanisms including 
cholesterol esterification, side-chain oxysterol synthesis, and down-regulation of synthesis through 
exportation.35Taken together, cholesterol’s unique structure allows for essential physiological 
modulation of lipid bilayers altering physiochemical properties and subsequent components within 
the membrane environment.  
 
1.2     Role of Lipids on Protein Activity 
The lipid membrane historically has been considered a passive protein-anchoring 
environment enabling proteins to mediate cellular functions. More recently, the membrane has 
been redefined as a medium that engages directly and specifically with an array of proteins 
including channels, transporters, and enzymes.45 Proteins embedded within or contiguous with the 
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lipid bilayer interact intimately with lipids and these interactions modulate their structure and 
function.46,47 Minor structural changes to lipids (head group, tail length, and saturation) can alter 
the structure and properties of the bilayer, as well as affect protein function via direct binding 
interactions, increasing the difficulty to distinguish each specific lipid influence from a diverse 
network of membrane lipids.48  
It is difficult to accurately differentiate specific protein-lipid interactions (including 
hydrogen bonding, hydrophobic effects, and charge interactions) from global membrane 
alterations (including fluidity and tension) that influence protein function.47,49,50 In addition to bulk 
lipids which have stable dynamic properties, a population of lipids have motional constraints 
through interactions either of low affinity hydrophobic surfaces (annular) or high affinity sites in 
clefts of protein surfaces or subunit interfaces (non-annular).51 Acyl tail length and head group 
variation  drastically alters hydrophobic bilayer size and intermolecular interactions critical for the 
stabilization of proteins.50 These dynamic interactions of the protein-lipid interface can be within 
microdomains of the membrane and are dependent on lipid compositions that modulate either 
direct lipid binding/interaction with protein or the physiochemical properties of the bilayer.52–54  
Protein activities may be modulated by bilayer properties (thickness and curvature) conversely to 
lipid fluctuations (membrane deformation and lipid sorting mechanisms) induced by hydrophobic 
mismatch of protein hydrophobic region.55,56 An example of bilayer-induced protein modulation 
is bacterial mechanosensitive channels where bilayer tension alters the open state probability of 
channels.57 Similarly, the monomer-dimer equilibrium of the amyloid precursor protein is altered 
by differential membrane thickness due to varying membrane compositions.58 A comprehensive 
understanding of the influence lipids have at the protein-lipid interface is essential to completely 
discern peripheral and integral membrane protein function.45 
 8 
 
 
1.2.1     Membrane Proteins 
Lipid membrane composition and structure can be targeted to alter localization and activity 
of proteins within signaling cascades implicated in diseases like cancer and diabetes.59 An example 
of this “membrane lipid therapy” is seen by the modulation of specific interactions of DAG, PS, 
and PE with protein kinase C isozymes favoring recruitment into microdomains.60,61 Thus, 
distinguishing complex protein-lipid interactions can offer therapeutic benefits.   
The structure and function of membrane proteins can also be affected by specific lipid-
protein interactions. For example, the β2-adrenergic receptor dimer interface is stabilized by 
cholesterol occupancy.62 Delipidation of interfacial lipids, including cardiolipin, alters oligomeric 
stability of Na+/H+ antiporters and bacterial leucine transporter diminishing dimer formation.63 
GPCRs localization, activation, and signal propagation are regulated by specific lipid interactions 
and membrane composition.61 Similarly, activity of SERT is cholesterol dependent as cholesterol 
depletion caused loss of substrate affinity, ligand binding, and transport rate reduction and 
recovery of activity required incubation with cholesterol as opposed to other sterols tested 
(ergosterol, 5-cholestene, pregnenolone), suggesting essential specific cholesterol interactions.64  
Lipids are frequently observed tightly bound to proteins with over 100 unique lipid binding 
sites identified in x-ray diffraction, nuclear magnetic resonance spectroscopy, and electron 
crystallographic studies, further underlining the importance of specific protein-lipid interactions.65 
Annular phospholipid interactions observed in x-ray crystallographic studies of bacteriorhodopsin 
show over a dozen tightly bound lipids depicting bilayers exposing protein surface interactions.66 
Non-annular lipid interactions are observed in K+ channels and cytochrome bc1 complexes in more 
buried regions between adjacent monomers of oligomeric complexes and subunits of multisubunit 
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complexes, respectively.67 Cholesterol interactions are maintained in structures including the 
glutamate receptor,68 Na+,K+ adenosine triphosphatase (ATPase),69 β2-adrenergic receptor,70 and 
dopamine transporter,71 highlighting cholesterol specific interactions of membrane proteins. Taken 
together, the presence of a variety of lipids maintained in current structures demonstrates how 
essential these molecules are in the stabilization of membrane proteins.   
 
1.2.2     Lipids and Ion Channels 
The lipid bilayer and its dynamic composition creates a modulatory environment for ion 
channels (including pentameric ligand-gated ion channels (pLGICs)).72–74 Current ion channel 
structures including glutamate-gated chloride channel (GluCl),75 K+ channels,76 and Gloeobacter 
ligand-gated ion channel (GLIC)77 reveal lipids bound at both the periphery annulus of the 
channel77 and non-annularly.75,76 Agonist binding of GluCl is modulated by select lipids through 
binding of membrane-spanning intersubunit crevices potentiating the receptor in an expanded, 
open-like conformation.75 Phosphatidylinositol 4,5-bisphosphate regulates inward rectifying 
potassium channels, acting as a coupling agent inducing large conformation changes of the 
transmembrane domain (TMD)-C-terminal domain association.78  
Cholesterol is an essential component of eukaryote membranes, and this specific lipid has 
been shown to affect ion channel structure and activity. Cholesterol reversibly affects γ-
aminobutyric acid receptor (GABAR) activity as cholesterol depletion reduces activity and this 
can be restored through cholesterol enrichment of cholesterol-depleted neurons.79 A variety of 
additional ion channels (inwardly-rectifying K+, Ca2+-sensitive K+, voltage-regulated anion, 
vanilloid transient receptor potential channel, voltage-gated K+, voltage-gated Na+, and voltage-
gated Ca2+ channels) similarly display cholesterol sensitivity, as reduction in cholesterol content 
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in membranes suppresses activity by decreasing open state probability, unitary conductance, or the 
number of active channels in the membrane.80 Although decreasing cholesterol concentration 
typically down regulates channel activity, a few cases such as G protein inwardly rectifying 
channel display up regulation of channel activity during cholesterol depletion.81 Cholesterol and 
anionic phospholipids modulate nAChR function where membrane cholesterol enrichment up to a 
given threshold (~35 mol%) enhanced receptor-mediated ion flux.82–86 This profound regulatory 
effect of cholesterol on nAChR is due to distinct asymmetric cholesterol-dependent conformations, 
where the allosteric coupling between neurotransmitter binding sites and the transmembrane pore 
is lost, termed the “uncoupled state”, in the absence of cholesterol or anionic phospholipids.87,88 
Altogether, lipids play a critical yet unresolved role in ion channel function due to the complexity 
of lipid molecules and effects produced to each specific protein.  
 
1.3     pLGIC Channel Allostery 
1.3.1 3.1     pLGIC Superfamily Structure 
 The pLGIC superfamily is essential for rapid neuronal communication through conversion 
of a chemical signal to an electrical impulse.89 pLGICs are found in a variety of organisms from 
single archaea to several bacteria species and complex vertebrates like humans.89 pLGICs evolved 
from a single ancestral gene to share an overall common architecture which provides an array of 
structural models to one another for probing receptor topology.90,91 Mammalian pLGIC orthologs 
are abundant in neuronal networks with regions including neuromuscular junctions as well as 
neuronal synapses in the peripheral and central nervous systems.89 pLGICs are comprised pseudo-
symmetric arrangement of five subunits forming a central ion-conducting pore.92 The activity of 
these channels is generally correlated with the selectivity of this pore as cationic channels such as 
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the nAChR and serotonin receptor (5HT3-R) are excitatory and anionic such as GABAR, GluCl, 
and GlyR are inhibitory.93 pLGICs are known  as  “Cys-loop” receptors due to a typically 
conserved 13 amino acid loop enclosed by a pair of disulfide-bonded cysteine residues within the 
extracellular domain (ECD).92,94 
All pLGIC subunits share a common global domain organization and common 
transmembrane topology,89 with each subunit consisting of a large N-terminal β-sandwich 
immunoglobulin-like structure ECD harboring the agonist binding site at the interface of adjacent 
subunits, a transmembrane domain containing four membrane-spanning α helices, and an 
intracellular domain (ICD) consisting of largely heterogenic transmembrane helix connecting 
loops (Figure 2).93,95,96 
 
Figure 2. pLGIC GlyR pentamer. Multiple GlyR topology views of cryo-electron microscopy zebrafish GlyR 
structure (PDB #3JAD) adapted from Du et al. (2015).100 The large globular ECD includes Cys-loop and ligand 
binding domain (see side view and top-down).TMD helices form the central pore (see bottom-up view). The M3-
M4 loop and the C-terminal tail are removed. 
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Most eukaryotic pLGICs are heteromeric assemblies, with multiple homologous subunit 
species within a single pLGIC labeled α, β, γ, etc, which are further divided into subtypes: α1, α2, 
etc.93 Recent structures of both prokaryotic (Erwinia chrysanthemi ligand-gated ion channel 
(ELIC),97 GLIC98 and eukaryotic (GluCl,99 GlyR100) channels show high conservation of the 
structures of both the ECD and TMD comprising of the majority of the channel (Figure 2). The 
minimally characterized intracellular M3-M4 loop region is least conserved among pLGICs having 
a wide range of sequence length and divergence.101 Therefore, it is typically removed or truncated 
in most pLGIC models due to the increased heterogeneity and lack of structural stability making 
it difficult to generate sufficient resolution.96  
 
1.3.2     pLGIC Superfamily Function and Significance 
Electrochemical gradients consist of two driving forces of ion movement across a 
membrane: an electrical driving force and a chemical (concentration) driving force.102 The 
electrical drive force contributing to the membrane potential arises when the electrical charge on 
two sides of a membrane differ due to unequal amounts of charged ions.18 The chemical or 
concentration driving forces arises due to asymmetric concentrations of each ion on both sides of 
a membrane. Together these forces create an electrochemical gradient, with the reversal potential 
(also known as the Nernst potential) occurring when no net flow of a particular ion occurs.18,102  
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The pLGIC superfamily contributes to all central nervous system functions that include sensory 
and motor processing, central autonomous control, memory, attention, sleep, wakefulness, reward, 
pain, anxiety, emotions, and cognition.103 Channel activation involves long range allosteric 
conformational rearrangements initiated by ligand binding that propagates movements ultimately 
disrupting the permeation gate, producing a transient open, ion-conducting channel (Figure 3).104 
Passive movement of ions down their electrochemical gradient alters the membrane potential 
affecting the resting potential across the membrane allowing rapid movement of ions across an 
otherwise impermeable hydrophobic membrane, endowing millisecond cellular 
communication.105,106 Influx of cations (Na+, K+, Ca2+) typically depolarize membrane potential 
while anion (Cl-) influx induces membrane hyperpolarization.107 Continued presence of bound 
ligand causes further structural rearrangements to a long-lived non-conducting desensitized state 
refractory to further activation.104,108 Channels recover from desensitization relatively slowly, 
transitioning to apo-structures that can be ligand-activated and continue the thermodynamic 
cycle.109 
 
Figure 3. Major ion channel states. Simplified cartoon depiction of allosteric transitions from the apo-state 
(Resting/Closed) to the ligand-bound ion conducting state (Open) to the ligand-bound non-conducting state 
(Desensitized).257 
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The pLGIC superfamily’s ability to modulate neuronal and muscular activity coupled with 
their sensitivity to a variety of drugs has made this superfamily of ion channels attractive and 
significant pharmaceutical targets.110 pLGICs are targeted by drugs such as nicotine, alcohol, 
cannabinoids, and benzodiazepines.93,111 Both nAChRs and 5-HT3Rs are major targets in drug 
discovery for several psychiatric, neurological, and peripheral disorders, leading beyond clinical 
trials to marketed drugs.112,113 Additionally, pLGICs malfunction are implicated in serious 
conditions such as Alzheimer’s disease,114 Parkinson’s disease,115 epilepsy,116 smoking 
addiction,117 and alcohol dependence.118  Defects in GlyR activity underlie pathological 
mechanisms of various neurological diseases such as startle disease (hyperekplexia) where 
missense mutations in genes encoding GlyR subunits cause glycinergic dysfunction leading to the 
neurological disorder.119 Inadequate clinical efficacy and adverse side effects occurring in 
gastrointestinal and the central nervous system (CNS) are the major current barriers in therapeutic 
strategies, emphasizing the necessity for discovery and refinement of therapeutic small molecule 
modulators.112 Further refinement of allosteric ion channel structure at drug interaction is essential 
for the understanding of the nature of specific drug action onto the pLGIC therapeutic targets.95 
 
1.3.3     GlyR Allostery 
The inhibitory GlyR is comprised of α (α1-4, ~48 kDa) and β (β1, ~58 kDa) subunits that 
typically assemble pentamerically at a 2α:3β ratio.120 Functional homopentameric α subunit 
channels can be overexpressed for biochemical and biophysical characterization,121 however β 
subunits are required for physiological postsynaptic clustering due to high affinity binding of its 
M3-M4 loop regions with gephyrin scaffolding.122 Each subunit ECD contains the characteristic 
Cys-loop within a ten strand β-barrel-like (β1-10) structure with two short α-helices connecting β3 
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and β4.123 Glycine ligand binds at the interface of two adjacent subunits in the ECD, and this 
neurotransmitter binding site is located between three loops “A-C” of the principal subunit and 
three β strands (β1,β2, and β5) of the complementary subunit.100,123 Upon glycine binding, GlyR 
allosterically transitions to a transient open conformation, where channels become permeable to 
small anions such as chloride, resulting typically  in Cl--influx and hyperpolarization.124 The TMD 
of GlyR (M1-M4) is connected by extracellular (M2-M3) and cytoplasmic (M1-M2, M3-M4) 
loops where M2s forming the central ion pore flanked by M1/M3, and M4 associated with M1/M3 
most distant from the pore (Figure 4).125 The channel gate(s) corresponds with the narrow channel 
pore region(s) at residues near the TMD:ICD interface critical for charge selectivity whereby 
residue side chains help control the electrostatic environment and create selectivity filters.106,126 
The TMD connecting loops, specifically the M1-M2 and M2-M3 loops flanking M2, interact with 
proximal regions of the ECD/ICD including the ligand binding domain and are also involved in 
channel gating.127,128 The eighteen length amino acid binding site of gephyrin,129 as well as 
endocannabinoid interactions130 with GlyR, are mapped to the M3-M4 loop. Immediately 
downstream of transmembrane helix M3 within the loop resides a cluster of basic residues 
containing topological information imperative for localization.131  
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1.4     pLGIC Pharmacology 
 
1.4.1     Pharmaceutical Agents and Bioactive Lipids 
 An array of pharmaceutical agents (anesthetics, barbiturates, benzodiazepines, 
cannabinoids, and alcohol) and bioactive lipids (progesterone, sphingomyelin, and ceramide) 
specifically targets the pLGIC superfamily of ion channels.111,132–134 Anesthetics generally 
potentiate inhibitory anion-permeable channels while inhibiting excitatory cation-permeable 
channels, observed in the general anesthetic propofol enhancement of GABA and GlyR agonist-
induced activation with inhibition of 5-HT3R and nAChR channels, however the molecular 
mechanism of channel modulation remains unresolved.135,136 In a similar manner, barbiturates 
modulate a variety of neuronal receptors both cationic (including α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptor, kainite receptor, nAChR, and 5-HT3R) and anionic (including 
 
Figure 4. GlyR single subunit structure. Simplified diagram of GlyR single subunit, illustrating domains of the 
subunit.258 The extracellular domain features both N- and C- termini, a large pre-M1 globular region, and the M2-
M3 loop. The transmembrane is comprised of M1-M4 α helices. The intracellular domain consists of the M1-M2 
loop and M3-M4 loop. 
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GABA, and GlyR) through inhibition and enhancement, respectively.137 Endocannabinoids are 
direct GlyR allosteric modulators with both positive and negative modulation based upon 
endocannabinoid subtypes with Δ9-tetrahydrocannabinol exhibiting positive modulation, 
highlighting relevant cannabinoid-induced analgesia strategies in pain therapeutics.130 At least 
GlyRs and GABARs of the pLGIC superfamily demonstrate sensitivity to allosteric modulation 
by n-alcohols (ethanol and butanol) that bind/interact in generally hydrophobic pockets/regions of 
which are closely associated or within the lipid membrane.138,139  
 Bioactive lipids also play a diverse role in modulating pLGIC activity.  Amongst their 
effects are regulation of cell-surface nAChR levels,134 the inhibition of GABAR,133 and the 
modulation of nAChR desensitization.140 Lipoprotein(a) is linked to the generation and 
maintenance of pain by modulating ion channel/receptors signaling pathways and gating properties 
through specific direct interactions.141 Cannabinoid-like GlyR potentiator screening providing an 
effective tool to discover novel interactions,111 highlighting the necessity to develop methodologies 
that accurately probe and refine protein-lipid interactions. Collectively, there are at least 170 
compounds (psychiatric medications, anesthetics, anticonvulsants, natural extracts, amino acids, 
ions, endogenous substances, drugs of abuse, and miscellaneous medications) of 
electrophysiological studies that can promiscuously modulate a subpopulation of LGICs (GABA, 
nAChR, GlyR, and 5HT3) suggesting extensive  interactions that require characterization to not 
only increase efficacy but to also provide templates to guide drug development.142 Intriguingly, 
both anesthetics and bioactive lipids partition with the cellular membrane specifically at the lipid-
protein interface,143,144 with anesthetics observed in crystal structures of pLGIC structural 
homologues,145,146 providing tremendous opportunity to discern molecular mechanisms of pLGIC 
allostery.135  
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1.5     Photocrosslinking Coupled with Tandem Mass Spectrometry 
 
1.5.1     Crosslinking Studies 
 Hundreds of thousands of protein interactions stemming from approximately twenty 
thousand protein-encoding genes create a dynamic protein-protein interactome network 
underlying all biological processes.147 The elucidation of these vast diverse networks provides 
insight into protein regulation and function.148 The majority of proteins function through complex 
assemblies including dynamic non-covalent associations of individual proteins, highlighting the 
potential to link interactions at a longer time scale.149 A novel method of elucidating protein 
interactions within networks is through protein crosslinking comprised of chemical, enzymatic, or 
chemoenzymatic formation of covalent bonds between polypeptides.150 By introducing a stable 
chemical linkage, transiently associated species establish a permanent interaction that previously 
would be difficult to detect and define.151  
 Crosslinking occurs naturally through enzymatic-catalyzed linkages seen by 
transglutaminases, sortases, and lysyl oxidases in various protein matrices.150 General crosslinking 
to immobilize protein environments within cells is commonly completed using formaldehyde, an 
efficient cell-permeable small compound creating DNA-protein, RNA-protein, and protein-protein 
crosslinks. Glutaraldehyde is one of the most effective and commonly used crosslinking reagents 
due to the variety of different forms of the compound yielding a vast range of suitable conditions 
like pH, temperature, and concentration, making it one of the most efficient crosslinkers for protein 
and enzyme immobilization.152 The amine-reactive N-hydroxysuccinimide esters are sensitive to 
primary amines, namely lysine residues, making it an effective crosslinker to proteins in living 
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cells allowing the probing of three-dimensional structures.153 Maleimide-based crosslinkers react 
rapidly to sulfyhydryl groups with minor reactivity with amino groups, allowing for intramolecular 
crosslinking of protein subunits.154 Given the variety of approaches for in vitro and in vivo 
crosslinking utilizing multifunctional crosslinkers (including homobifunctional and 
heterobifunctional) with varying length and reactive groups generates enormous diversity of 
available crosslinking reagent-based methodologies.150 
 Photoaffinity labels offer reproducible labeling in time- and location-specific manner in 
the presence of ultraviolet light to the target protein.155 Photoaffinity labeling features a light-
sensitive reactive motif for covalent linkage and commonly employed in drug discovery, drug 
target binding, and protein-ligand interactions having the advantage as useful tools in live cells 
and physiologically relevant systems to convert transient short-lived interaction into permanent 
covalent bonds amenable to a variety of analysis techniques.156,157 Azide photocrosslinking (Figure 
5, Right) chemistry is commonly used to obtain structural constraints in biological systems through 
 
Figure 5. Photoreactive crosslinkers. Two examples of many photocrosslinkers available. The 
diazirine motif (Left) creates carbene intermediates for concerted addition reactions. The azide 
motif (Right) creates nitrene intermediates for addition reactions.259 
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formation of reactive nitrene intermediates targeting primarily C-H and C=C bonds for addition 
reactions, characterizing the higher order structure of RNA and RNA-protein complexes.158,159 
Benzophenone crosslinkers typically react with unreactive C-H bonds having mapped nucleotide-
binding sites in ATPases and confirmation flexibility in solution, micelles, and membranes.160 In 
particular, diazirines (Figure 5, Left) are commonly utilized photoreactive probes to study ligand-
receptor, ligand-enyzme, and protein-protein interactions.161   
  
1.5.2     Mass Spectrometry 
 In modern proteomics, mass spectrometry is increasingly utilized and rapidly advancing 
the variety of approaches and instrument resolution to elucidate cell protein compositions, complex 
formation, stoichiometry, architecture, and dynamics.162 The application of mass spectrometry to 
proteomics is the use of one or more techniques from a collection of methodologies (sample 
preparation, chromatography systems, mass analyzers) where each can have particular strengths 
suited to specific investigations, all based upon the measurement of mass-to-charge ratios of gas-
phase ions.163,164 In general, analyte enters the ionization source where molecules are converted to 
the gas phase and ionized, directed into a variety of mass analyzers separating ions based upon 
mass-to-charge ratios through modulation of electric and magnetic fields, ultimately reaching the 
detector to be measured (Figure 6).164,165 Advances in modern mass spectrometry have lead to the 
development of methodologies achieving extraordinary mass accuracy (>2ppm), resolving power 
(>100,000), and limit of detection (sub-nanogram).166,167 
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 The implementation of tandem mass spectrometry (MS-MS) analysis has become an 
essential tool in the analysis of protein identification, complex structures, and protein 
modifications, where precursor ions are selected, activated through energetic collisions with 
neutral gas causing dissociation into product ions that reveal additional information about the 
protein, complex, or analyte assayed.168–170 For protein and peptide based MS analysis, the most 
commonly employed ionization sources for mass spectrometers are soft ionization methods 
including matrix assisted laser desorption ionization and electrospray ionization (ESI) that can 
preserve native structure and complexes entering the mass spectrometer which are then 
discriminated typically by quadrupole, time-of-flight, or ion trap analyzers with the inclusion of 
collision cells for fragmentation.171  
 Given the sample’s potential complexity, the implementation of high performance liquid 
chromatography (HPLC) preceding mass spectrometry increases the dynamic range and 
 
Figure 6. Quadrupole time-of-flight schematic. For tandem MS experiments, ions from the 
source enter and are filtered through the quadrupole, enter the collision chamber for 
fragmentation, and finally enter the time-of-flight tube for ion separation before reaching 
the detector.260   
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identification coverage of analyte through separation based upon analyte interactions with 
chromatographic stationary and mobile phases.172 In determining protein complex composition, 
the dissociation of subunits follows a predominant fragmentation pathway with the expulsion of 
mono/multimeric protein subunits sequentially from the now stripped complex, allowing for the 
elucidation of subunit organization and stoichiometry.169 Varying dissociation pathways in 
response to increased collision-induced dissociation (CID) energy are observed in peroxiredoxin 
ring assembly MS studies where dimers preferentially associate as intermediate pentamers, 6-mers, 
and 8-mers, with subunit dissociation as dimers opposed to monomer dissociation.173 The MS-MS 
peptide dissociation pathway using CID provides reproducible fragmentations typically through 
cleavage of an amide bond  (denoted as “b” ions if charge retained on N-terminus fragment and 
“y” if retained on C-terminus fragment) in the peptide providing information regarding the specific 
order of amino acids in smaller fragments stemming from the original peptide (Figure 7).174,175 
This is commonly employed in protein sequencing or modification assays where MS-MS 
fragmentation produces unique product ions that are compared with potential sequence masses in 
secession and/or refines the targeted modification location from a peptide to potentially single 
 
Figure 7. Collision-induced fragmentation pattern. Diagram of CID product ions produces after 
precursor ion fragmentation. CID typically produces “b” and “y” ions with less occurring “a” 
ion production.261 
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amino acid resolution.176 Advances in MS instrumentation have allowed for the analysis and 
identification of low abundant crosslinked peptides from complex biological samples providing 
more comprehensive and complete information for studies.177 
 
 
1.5.3     CX-MS as a Biochemical Tool 
 Current CX-MS strategies capture both the identity and connectivity of protein-protein 
interactions from their native cellular environment.177 The incorporation of sensitive MS-based 
approaches to photocrosslinking workflows allows for the potential to not only map protein-
protein interactions but also identify allosteric dynamics of protein structure and interactions with 
its environment.178,179 The transient nature of protein dynamics, exemplified in neuronal receptor 
allostery, typically poses a challenge for characterization, however the approach of using 
photocrosslinking provides a dynamic representation of protein alterations including receptor 
gating and desensitization.179,180 Crosslinking reagents are of a defined length resulting in distance 
constraints (shortest distance between linked amino acids given protein volume) essential for 
structural validation, modeling, and de novo prediction.177  
 Photoaffinity labeling coupled with modern MS instrumentation can provide additional 
structural and mechanistic information compared to other photolabeling techniques regarding 
protein complexes, ligand-receptor stoichiometry, binding pocket maps, and single amino acid 
binding resolution.181 CX-MS is rapidly advancing becoming a promising approach to gain 
structural information on large, potentially transient protein assemblies, intrinsically disordered 
proteins, and protein interaction networks both in vivo and in vitro.182 Current tandem MS 
instruments have the mass accuracy and sensitivity to unambiguously identify and refine 
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crosslinked species to amino acid residue(s) within a given peptide.178,183,184 CX-MS has be used 
to guide complementing structural techniques like crystallography in protein complex 
crystallization and conversely employed to verify and refine pre-determined crystal structures.185 
Interaction networks of mitochondrial proteins analyzed in vivo generating mitochondrial 
interactomes highlight capabilities where native molecular environments need to be maintained.186 
 CX-MS in conjunction with computational modeling elucidated a comprehensive protein-
protein interaction network of proteasome complexes generating nearly 500 linkages of both inter- 
and intra-protein interaction highlighting structural dynamics and conformation 
heterogeneity.177,187 The ability of coupling additional quantification techniques to CX-MS studies 
to not only identify specific interactions but report the frequency of interactions, observed in 
calmodulin quantification of substrate interactions which determined the abundance of complex 
formations, demonstrating the ability of crosslinking to be quantified by traditional calibration 
curve or isotope dilution methods.188,189 Photoaffinity labeling coupled with MS has the capability 
to map lipid accessibility of proteins and protein:lipid interactions elucidating the propofol binding 
site of GLIC190 and GABAR191 as well as cholesterol interactions with the peripheral-type 
benzodiazepine receptor (PBR),192 voltage-dependent anion channel-1,193 nAChR,194,195 and 
GlyR.178 The coupling of these techniques highlights the advantages of providing more 
comprehensive information of greater detail, sensitivity, and less analysis times than traditional 
biophysical labeling techniques.181  
 
1.5.4     Advantages and Limitations 
 The most basic and essential advantage of CX-MS is the generation of covalent bonds 
between target protein/lipids that can by highly specific and of high capacity, stabilizing a long-
 25 
 
lived association amenable for analysis.196 An essential benefit of in vivo CX-MS is to characterize 
structural information (cellular compartmentalization, concentrations, interacting partners) within 
native environments at or near physiological conditions.197 CX-MS assays can be a quick and 
convenient approach that does not require a large amount of protein or at high purity and is 
applicable to a variety of proteins and protein complexes after minor affinity purification.198 In 
most cases, the performance of CX-MS does not depend on the length, size, or tertiary structure 
of proteins being beneficial in analysis of large proteins and disordered regions of proteins.198 
 Taking advantage of MS exquisite accuracy and resolution, CX-MS studies have the 
ability to unambiguously identify crosslinks within proteins upon fragmentation to refine the 
modification site.199 For substrate binding studies compared to computational methods, CX-MS 
does not require prior structural knowledge or information of the protein or binding site of 
interest.198 Multifunctional crosslinkers offer users the ability to select the initial attachment 
allowing for precise positioning of the crosslinker within the protein for improved crosslinker 
functionality.200 Comprehensive structural data can be additional acquired through the combination 
of varying lengths crosslinkers within single experiments.201 Targeted quantitative CX-MS of 
crosslinked peptides accurately quantifies dynamic changes in protein structure, complexes, and 
interactions or varying experimental conditions and biological states, allowing for state-dependent 
mapping of protein-protein or protein-lipid interactions.202 
 One of the most prominent limitations of CX-MS studies is the requirement of high-
resolution mass spectrometry instrumentation coupled with an efficient enrichment process of 
desired crosslinks given the low population of crosslinks within complex samples.203 CX-MS can 
generate uneven distribution of crosslinking within a protein structure influenced by enzymatic 
digestion site distribution.201A limitation of CX is that crosslinkers generate artificial crosslinks 
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more prominent with longer crosslinker spacers, requiring greater effort of independent validation 
of identified crosslinks.196 Crosslinker:protein ratios are kept low to avoid structural perturbations 
including crosslinker-induced polymerization.203  
 When targeting specific regions of protein/complexes, the crosslinker must be accessible 
to the desired site(s) of interest to interact and provide information.150 Distance constraints crested 
through current crosslinkers may not have the resolution to resolve structural arrangements such 
as β-sheets.201 A restriction or bottleneck of CX-MS studies arises during MS data analysis due to 
the lack of automated algorithms and programs to process both MS and MS-MS spectra limiting 
throughput stemming from the large diversity and uniqueness of individual assays as well as highly 
complex spectra with low signal intensity.204 
 
1.6     Cholesterol-GlyR Interactions 
 
1.6.1     Rationale 
 Lipid interaction studies with nAChR83,86 demonstrate the requirement of cholesterol in 
bilayers for ion channel activity and asymmetric interactions based upon concentration. 
Cholesterol concentrations (>25 mol% and 40 mol%) were selected given cholesterol’s activity 
threshold of ~33 mol%40 coupled nAChR activity studies showing enhanced cholesterol-mediated 
ion flux up to ~35 mol % cholesterol membrane content,86 correlating both lead to the hypothesis 
that if cholesterol crosslinking was used to analyze cholesterol accessibility to GlyR under both 
concentrations (<25 mol% and >40 mol%), the cholesterol accessibility/crosslinking pattern of 
<25 mol% would be entirely contained within the pattern of cholesterol accessibility/crosslinking 
of >40 mol% with additional crosslinking solely observed in the >40 mol% studies. Conversely to 
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traditional binding site studies, the <25 mol% crosslinking is hypothesized to be non-specific 
random interactions due to cholesterol’s negligible activity while the >40 mol% crosslinking is 
hypothesized to be a collection of both non-specific interactions (observed in <25 mol% studies) 
and specific interactions unique to the elevated cholesterol condition.  
 It is hypothesized that azi-cholesterol-GlyR CX-MS studies can provide state-dependent 
differential crosslinking patterns that capture dynamic structural information about individual and 
distinct GlyR conformations. pLGICs including GlyR display distinct allosteric state 
conformations and when coupled with the ability to stabilize GlyR in the resting, open, and 
desensitized states allow the interrogation of state-dependent cholesterol interactions. This CX-
MS study can not only elucidate concentration- and state-dependent effects on the GlyR-
cholesterol interaction profile, but also reveal structural information (lipid accessibility through 
bilayer proximity and/or hydrophobic pockets) about unresolved portions of GlyR (M3-M4 loop 
and C-terminal tail). It is hypothesized that crosslinking identified in open state studies is a 
combination of crosslinking from channels sampling both resting- and open-like conformations 
and that crosslinking uniquely identified in open-state datasets are representative of the open state 
confirmation. Similarly, it is speculated that crosslinking identified under desensitizing conditions 
is a collection of crosslinking from channels sampling the resting, open, and desensitized 
conformations. Comparative studies can similarly be used to find unique crosslinks not observed 
in resting and open-state studies, such that crosslinking can be attributed to the desensitized 
receptor.  
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1.6.2     Experimental Overview 
 Given the essential, yet undefined role of cholesterol’s modulation of pLGICs as well as 
other membrane proteins, we examined cholesterol accessibility of homomeric α1 GlyR in a 
concentration- and state-dependent manner using CX-MS. CX-MS concentration-dependent 
studies were conducted on apo-state GlyR at <25 mol% and >40 mol% cholesterol content within 
the lipid membrane. Resting state studies, performed previously178 using WT apo-GlyR stabilize 
channels in a unbound, non-conducting manner.  Azi-cholesterol, a photoactivatable cholesterol 
analog non-specific probe, was used to covalently capture cholesterol-GlyR interactions with equal 
incorporation into both concentration studies (<25 mol% and >40 mol%). To further define 
cholesterol’s role in pLGIC modulation and expand on the apo-state GlyR studies, state-dependent 
cholesterol crosslinking was conducted on GlyR in conditions stabilizing the open and desensitized 
states at >40 mol% cholesterol in the lipid membrane. Open state studies were completed on a 
doubly mutant (F207A/A288G) GlyR in the presence of ivermectin (30 nM) yielding an 
ivermectin-sensitive non-desensitizing channel.205 Desensitized state studies were conducted in 
the presence of saturating concentrations of glycine, stabilizing WT GlyR in a higher-affinity 
ligand-bound desensitized conformation. This study shows that photocrosslinking coupled with 
tandem MS can map a lipid-protein interface in several allosteric states/conformations, depicting 
lipid accessibility during transient structural changes. Direct cholesterol-GlyR interactions have 
been identified in different allosteric conformations that can help refine GlyR 
crystallographic/cryo-electron microscopic models, principally in unresolved regions, provide 
insight into ion channel dynamics of gating and desensitization. 
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CHAPTER 2: APO-STATE CHOLESTEROL-GLYR INTERACTIONS 
 
2.1    Abstract 
 GlyR belongs to a superfamily of pLGICs that mediate fast neurotransmission. GlyR 
typically modulates inhibitory transmission by antagonizing membrane depolarization through 
anion influx. Allosteric interactions between the receptor and its lipid surroundings affect receptor 
function, and cholesterol is essential for pLGIC activity. Cholesterol at compositions below ~33 
mol percent has been shown to have negligible chemical activity, suggesting that specific 
interactions between membrane proteins and cholesterol become significant only at concentrations 
above this stoichiometric threshold. Human α1 GlyR was purified from baculovirus infected insect 
cells and reconstituted in unilamellar vesicles at cholesterol:lipid ratios above and below the 
cholesterol activity threshold with equivalent aliquots of azi-cholesterol, a photoactivatable non-
specific crosslinker. After photoactivation, crosslinked cholesterol-GlyR was trypsinized and mass 
fingerprinted.  Mass shifted peptides containing cholesterol were identified by ESI-Q-TOF MS, 
and sites of direct covalent attachment to peptides were refined by targeted MS-MS. Differential 
patterns of dozens of cholesterol-GlyR crosslinks were identified in these comparative studies, 
with sites of crosslinking found primarily in the fourth transmembrane helix and extramembranous 
connecting loops and mapping the lipid-accessible surface of the receptor. Unique crosslinking 
observed in both reduced and elevated cholesterol composition suggests different apo-state 
structural conformations of GlyR as a function of cholesterol concentration and, in the latter 
studies, identified potential specific binding sites for cholesterol in the receptor.  
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2.2    Introduction 
 The current model of the biological membrane suggests lipids and proteins are not 
homogeneously distributed and form microdomains, with cellular processes at membranes 
modulated as a function of its composition.52 Lipid composition alters the physicochemical 
properties of the bilayer, and this local environment may modulate the structure and function of 
membrane proteins.53,54 Striking examples of these effects include the different topologies 
exhibited by lactose permease as a function of phospholipid composition,206 the abrogation of 
dimer formation of the leucine transporter from cardiolipin delipidation,63 the lipid dependence of 
glucose transporter activity,207 and the effects of cholesterol on ion channels and other membrane 
proteins.80,208,209 Crystallographic studies have further highlighted the importance of these 
interactions as structures often contain specific bound lipids.65 For example, cholesterol has been 
co-crystallized with G-protein coupled receptors,65 Na+,K+ ATPase,69 and the dopamine 
transporter.71  
 Sterols preferentially associate with increasing acyl chain saturation of phospholipids and 
with sphingolipids, forming complexes and microdomains that target the transmembrane regions 
of some proteins.210,211 Cholesterol in molar excess of the capacity of these complexes has high 
accessibility and fugacity, and will be referred to as “active cholesterol”.36 Above this 
stoichiometric threshold   there is a sharp increase in sterol availability to cholesterol oxidase, 
perfringolysin, and methyl-β-cyclodextrin.37–39 Sterol availability typically emerges at 
concentrations above 25-35 mol percent and at lower concentrations it has negligible chemical 
activity.40,41 Membrane–intercalating amphihiles can activate cholesterol by displacing cholesterol 
from its lipid complexes.212 Consistent with these observations, cholesterol activity increases in 
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the presence of sphingomyelinase.213 Taken together, significant specific cholesterol-protein 
binding is expected to emerge only at higher cholesterol concentrations.  
 The interactions between pLGICs, the superfamily of ion channels that are essential for 
fast neuronal signaling between cells, and the surrounding lipids influence their function.72,73 
Lipids are proposed to allosterically modulate GluCl by inducing an expanded open-like 
conformation and by potentiating agonist binding.75 Both depletion and enrichment of membrane 
cholesterol reduced efficacy of GABAR channel activation.79 Cholesterol and anionic 
phospholipids have been shown to be a key modulator of nAChR function and critical for 
conformational transitions between allosteric states.82–84 In reconstituted lipid vesicles lacking 
cholesterol or phosphatidic acid, agonist fails to stimulate nAChR ion flux.85,86 Increasing 
cholesterol/phosphatidic acid concentration within the lipid environment enhances nAChR-
mediated ion flux and was found to saturate at ~35 mol percent cholesterol and ~12 mol percent 
phosphatidic acid.86 Below this concentration, nAChR favors a desensitized-like uncoupled state, 
while approaching and exceeding this threshold favors the resting state, which has the ability to 
undergo agonist-induced conformational transitions.214 
 A novel way of gaining structural information to further understand protein-lipid 
interaction is through the use of chemical crosslinking.215 Photoaffinity labeling studies directly 
identified the propofol-binding site of GLIC190 and GABAR.191 Cholesterol homologs were 
similarly used to map sites of cholesterol interactions with the PBR and putative cholesterol 
recognition amino acid consensus (CRAC) motifs were identified.192 Cholesterol photoaffinity 
probes have also characterized lipid-protein interactions of cholesterol and nAChR.194,195 In these 
studies, azi-cholesterol bound extensively to the M4 region within nAChR (~75%), as compared 
to the M1 and M3 segments (~25%), with binding regions congregated toward charged amino 
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acids located at the ends of the M4 segment, leading researchers to question whether peptide 
labeling is driven by proximity of the azi-cholesterol or by diffusional encounters with accessible 
side chains.194 The advent of MS methodologies offers the opportunity to more sensitively and 
specifically detect and map covalent crosslinks with lipids.  
 Given the essential, yet not completely defined role of cholesterol’s influence of 
membrane protein structure and function, we propose to examine the cholesterol accessibility of a 
paradigmatic pLGIC as a function of cholesterol concentration in comparative studies above and 
below its “activity” threshold. In this study we have focused on identifying non-specific 
(cholesterol at low mol percent) and specific (additional unique interactions with active cholesterol 
present only at high mol percent in comparative studies) interactions of cholesterol with the GlyR 
using CX-MS. The pentameric GlyR is typically comprised of two transmembrane subunit 
homologs (α and β) surrounding a central anion-selective pore arranged with a 2α:3β subunit 
stoichiometry.120 Each subunit consists of a large ECD followed by four transmembrane segments 
(denoted M1-M4) and an extracellular tail.125 The ligand-binding site is located at the interface 
between neighboring subunits in its ECD, with aromatic residues lining the binding pocket.216 
Upon binding of the neurotransmitter glycine, GlyR transitions to a metastable open state 
conformation, characteristically hyperpolarizing the post-synaptic neuron through chloride influx, 
and then a long-lived non-conducting desensitized state that more tightly binds glycine.217 The 
intracellular domain consisting of loop-like structures (M1-M2 and large M3-M4 loops) has roles 
in receptor trafficking and localization, and the M3-M4 loop contains a site of phosphorylation. 
However the structure of this large M3-M4 loop is poorly refined in studies of pLGICs, as it is 
typically excised in structural studies due to its expected flexibility. This region contains the 
greatest sequence diversity among pLGICs and has not been resolved in any pLGIC 
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structure,96,218,219 highlighting the importance of the development of methods that can provide 
information regarding the structure of the M3-M4 loop. The C-terminal tail after M4 is also poorly 
resolved in current structures. In addition, given that the structure and function of pLGICs is 
modulated by lipid composition (as described above), it is imperative to develop new 
complementary techniques that provide investigators with the tools to examine membrane protein 
structures in native-like reconstituted membranes in the absence of detergents. CX-MS studies can 
provide some of this complementary information. 
 Elucidating the lipid accessible regions of pLGICs are essential as modulatory anesthetics 
and bioactive lipids partition within the bilayer and their effects may be mediated through the lipid-
protein interface.143,144 Here, we analyzed cholesterol-human α1 GlyR interactions in the resting 
state of the receptor using photocrosslinking coupled with multidimensional MS. Advancements 
in MS technologies have improved the sensitivity and accuracy of detection in CX-MS 
experiments, increasing the number of low-intensity crosslinked peptides identified and subjected 
to tandem MS analysis.185 Current tandem mass spectrometers have the sensitivity and mass 
accuracy for the unambiguous identification of crosslinked species and through peptide 
fragmentation, allowing the identification of specific amino acid residue(s) involved in 
crosslinking.183,184 
 Given the differential activities of cholesterol at low and high mol percent, azi-cholesterol, 
a photoactivatable cholesterol analog, was crosslinked to wild-type human homomeric α1 GlyR at 
conditions that probe interactions when cholesterol has negligible chemical activity (<25 mol 
percent natural cholesterol in membrane) and when cholesterol is more chemically active (>40 mol 
percent natural cholesterol in membrane).42,220 Only at concentrations above this approximate 
threshold does one observe the emergence of free “liquid” cholesterol that is chemically active.220 
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This threshold correlates with the approximate concentration of cholesterol (~35 mol percent) 
required for functional nAChR.86 Therefore, it is speculated that in conditions where cholesterol 
has negligible chemical activity (<<33 mol percent), cholesterol would not specifically interact 
with potential cholesterol-binding sites in GlyR, as chemically inactive cholesterol is postulated to 
be sequestered among phospholipids and microdomains. Rather, identified crosslinks are 
hypothesized to result from random diffusional encounters of cholesterol and protein. Conversely, 
in chemically active cholesterol conditions (>>33 mol percent), the free “liquid” cholesterol is 
chemically active (it is postulated that at elevated concentrations, cholesterol’s affinity for lipid is 
exceeded) and is available to additionally interact specifically with GlyR, such that identified 
crosslinks are a result of specific and non-specific interactions with cholesterol. This study shows 
that MS can sensitively identify covalent sites of lipid-protein interactions, as picomoles of 
purified protein are sufficient to allow identification of dozens of sites of crosslinking in each 
experiment. These studies directly identify lipid-protein interactions and can aid in the refinement 
of GlyR structural models derived from crystallographic and cryo-electron microscopic studies, 
particularly in identifying cholesterol interactions with GlyR in reconstituted vesicles.  
 
2.3    Materials and Methods  
 
2.3.1    Purification of GlyR from Sf9 insect cells into mixed detergent micelles 
 Purified GlyR in mixed detergent/lipid micelles were isolated as previously described.121 
Briefly, WT human α1 GlyR was overexpressed in a baculovirus infected Sf9 insect cells. Three 
days post-infection Sf9 insect cells were gently pelleted, washed with 1 phosphate buffered saline 
(PBS) pH 7.4, and resuspended in a hypotonic solution (5 mM Tris pH 8.0, 5 mM 
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ethylenediaminetetraacetic acid (EDTA), 5 mM ethylene glycol tetraacetic acid (EGTA), 10 mM 
dithiothreitol (DTT)). An anti-proteolytic cocktail (1.6 µunits/mL aprotinin, 100 µM 
phenylmethanesulfonyl fluoride (PMSF), 1 mM benzamidine, 100 µM benzethonium chloride) 
was added to reduce protein degradation immediately preceding lysis. Cells were lysed by 
sonication followed by centrifugation (387,000 x g for 30 min) to isolate cell membranes 
containing GlyR. Cell membranes were washed with a resuspension buffer (hypotonic solution, 
300 µM NaCl) followed by centrifugation again to remove peripheral membrane proteins. The 
protein pellet was solubilized in 10:1 digitonin:deoxycholate buffer (12 mM mixed lipids (9:1 plant 
extract (95% phosphatidycholine purity, Avanti): egg extract (60% phosphatidycholine purity, 
Avanti) at 15 mg/mL, stored as suspended vesicles), 0.10 % deoxycholate, 1.0 % digitonin, 25 mM 
potassium phosphate monobasic, 79 mM potassium phosphate dibasic, 1 M KCl, 5 mM EDTA, 5 
mM EGTA, 10 mM DTT, anti-proteolytic cocktail) overnight, and solubilized micelles were 
isolated after centrifugation (387,000 x g for 1 hr). GlyR/lipid/detergent micelles were affinity 
purified on 2-aminostrychnine agarose and eluted competitively with the addition of excess 
glycine (2 M) to the solubilization buffer. 
 
2.3.2     Reconstitution of GlyR into lipid vesicles at defined concentrations of cholesterol,   
              incorporating azi-cholesterol 
 GlyR vesicle reconstitution was completed as previously described124 with the following 
modifications to the lipid composition. All steps were conducted in the dark and at 5˚C unless 
noted. Mixed lipids (9:1 plant extract (95% phosphatidycholine purity): egg extract (60% 
phosphatidycholine purity) at 15 mg/mL, stored as suspended vesicles) were added to purified 
GlyR/lipid/detergent micelles to yield a final concentration of 1.5 mg/mL. Cholesterol (15.07 mM 
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in methanol) was included to yield >40 mol percent and <25 mol percent for defined conditions. 
Azi-cholesterol was kept at constant concentrations in both conditions at 6 µM. As previously 
described, samples were added to dialysis cassette (3500 MW cutoff, Thermo) for dialysis against 
excess potassium phosphate buffer (6.25 mM, pH 7.4). The final reconstituted protein pellet was 
dissolved in potassium phosphate buffer (25 mM, pH 7.4). GlyR concentrations were quantitated 
using a modified Lowry assay.221  
 
2.3.3    Photo-crosslinking of Azi-cholesterol to GlyR and separation of crosslinked GlyR 
 Reconstituted GlyR vesicles were placed into quartz cuvettes on ice to maintain 
temperature. Cuvettes were exposed to a 420 W Hg Arc lamp (Newport, Model 97435-1000-1, 
260-320 nm) for 4 sessions of 5 minutes at 7 cm, with 5 minute periods of no exposure in between 
each UV exposure session to prevent sample warming. SDS-PAGE (11 % resolving, 5 % stacking) 
separated the crosslinked oligomeric and monomeric GlyR from lipids, with gel plugs excised 
between migration distances of 250 kDa and 37 kDa, encompassing the mass of oligomeric and 
monomeric forms of GlyR. 
 
2.3.4    In-gel Trypsin digestion of crosslinked GlyR 
 Gel plugs were washed with 50:50 absolute methanol: 50 mM ammonium bicarbonate 
twice for 40 min with gentle agitation (VWR Thermal Shake Touch, 900 rpm). Gel plugs were 
dehydrated by adding 500 L acetonitrile. Once gel plugs turned whitish, acetonitrile was removed 
and gel plugs were dried in an Eppendorf 5301 Vacufuge Concentrator for approximately 15 
minutes. Trypsin solution (10 L at 20 g/mL in 50 mM ammonium bicarbonate) was added to 
gel plugs and incubated on ice for 15 minutes, then incubated overnight at 37˚C with gentle 
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agitation (VWR Thermal Shake Touch, 900 rpm). Digested peptides extracted into supernatant and 
transferred to VWR non-stick microcentrifuge tubes. Tryptic fragments were further extracted by 
incubating gel plugs twice for 30 minutes in 300 L of 0.1 % formic acid in 50:50 acetonitrile:H2O. 
The supernatant was collected and combined with initial supernatant. Tryptic extract solution was 
dried in an Eppendorf 5301 Vacufuge Concentrator. 
 
2.3.5    Mass fingerprinting of crosslinked cholesterol to GlyR  
 50:50 Acetonitrile: H2O with 0.1 % Formic Acid (50 L) was added to tubes containing 
dried tryptic extracts. ESI-Q-TOF-MS measurements were taken using an Agilent 6530 Q-TOF-
MS with an Agilent HPLC-Chip II G4240-62006 ProtID-Chip-150, comprised of a 40 nL 
enrichment column and a 75 µm x 150 mm separation column packed with Zorbax 300SB-C18 5 
µm material. The mass spectrometer was run on positive ion mode using internal standards 
(1221.9906 and 299.2944) for calibration, supplied by Agilent. Mobile phase compositions used 
were Solvent A (95 % H2O, 5 % ACN, 0.1 % Formic acid) and Solvent B (95 % ACN, 5 % H2O, 
0.1 % Formic acid) The nanoflow elution gradient was developed as follows at 0.50 µl/min of 
Solvent A (minute: percent A): 0.00: 95 %, 4.00: 10 %, 6.00: 70 %, 9.00: 50 %, 11.50: 95 %, 13.00: 
95 %. Data were processed using Agilent Qualitative Analysis Software 6.0. Cholesterol 
crosslinked peptides within a 10 ppm accuracy window were identified, accounting for possible 
peptide modifications (oxidation, acrylamidation).  
 For MS-MS studies, crosslinked samples were run again on the Agilent 6530 Q-TOF-MS, 
targeting the specific m/z ratio, charge, and retention time of the crosslinked peptides identified in 
MS analysis. CID was used for MS-MS fragmentation following a linear increase in collision 
energy by m/z using the equation: y=3.7x+2.5. CID was performed at + 0.2 min from initial MS 
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scan retention time of each crosslinked precursor ion identified. Data were processed using Agilent 
Qualitative Analysis Software 6.0 in conjunction with ProteinProspector v5.14.3 available through 
the University of California, San Francisco.  
 
2.4    Results and Discussion  
 
2.4.1    Cholesterol crosslinking to resting state GlyR at reduced cholesterol composition 
 As noted previously, cholesterol is expected to exhibit very different chemical activity as 
a function of its concentration in reconstituted membranes, so comparative crosslinking studies 
conducted at low and high cholesterol composition can be used to potentially map non-specific 
and specific sites of protein-cholesterol interactions, respectively. Functional GlyRs were purified 
from baculovirus infected Sf9 insect cells121 and reconstituted into vesicles under conditions that 
have been shown to retain complete GlyR activity in outside-out orientations124 at selected lipid 
composition containing constant levels of mixed plant/egg phosphatidylcholine (12 mM) and 
photoactivatable azi-cholesterol (6 µM, Figure 8). 
 For comparative studies, the only variable was the cholesterol content in the vesicles, 
which was <25 or >40 mol percent, well below or well above the published typical threshold limits 
 
Figure 8. Chemical structure of photoactivatable azi-cholesterol. Chemical structure of cholesterol crosslinker 
analog, with the reactive site highlighted in blue. 
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for cholesterol activity,42,220 respectively. The lipid composition in reconstituted vesicles was 
chosen to reflect the generic lipid compositions (i.e., saturated and unsaturated acyl chains with 
various headgroups) found in the cell lines used in activity assays (HEK and insect cells), dynamic 
neuronal membranes56 and the studies examining cholesterol activity (described previously).86,40 
At <25 mol percent, cholesterol is expected to exhibit negligible chemical activity (sequestered in 
microdomains) and identified crosslinks to GlyR are ascribed to random diffusional encounters, 
and are expected to map the lipid accessible surface of the receptor. At >40 mol percent, cholesterol 
is expected to have much greater chemical activity and identified crosslinking will be due to 
specific interactions of the active cholesterol as well as non-specific random diffusional 
encounters. In comparing the two studies (low and high cholesterol), crosslinking unique to the 
>40 mol percent conditions are expected to be the specific cholesterol binding sites in GlyR, or 
changes in lipid accessibility of GlyR due to structural changes as a function of increased 
cholesterol concentration.  
 40 
 
 To identify lipid accessible surface of GlyR in its resting state that interacts with 
cholesterol in a non-specific manner, the total cholesterol was limited to <25 mol percent where it 
Table 1. Cholesterol crosslinking at reduced cholesterol composition. Identified mass-shifted precursor ions 
crosslinked with cholesterol (within 10 ppm error, identified in at least 2 of 3 trials) at <25 mol percent 
cholesterol conditions shown in left column. Sites of covalent modification identified upon analyses of product 
ions upon CID fragmentation are bolded and underlined; spaces separating amino acids represent single point 
amino acid crosslinking sites in succession. *Modifications of the precursor ion, including crosslinked 
cholesterol. Precursor ions identified with different combinations of modifications are shown for each precursor 
ion. Parenthesized numbers following “Azi” represent the number of crosslinked cholesterol(s) within the mass-
shifted peptide. 
Amino Acid Sequence 
Structural 
Location 
Modifications* 
60VNIFLR65  
 
 
Pre-M1 
ECD 
 
Azi 
60VNIFLRQQWNDPR72 
Azi (3) 
Azi (4) 
191EEKDL RYCT K200 
Azi, Acryl (2) 
Azi (2), Acryl 
Azi (2) 
Azi (3) 
194DLRYCTK200 
Azi 
Azi, Acryl 
310QHKELLR316 
M3-M4 
Loop 
Azi (4) 
313ELLRFRR319 Azi 
321RRH H K325 
Azi 
Azi, Ox (2) 
Azi (2), Acryl 
323HHKEDEAGEGR333 Azi, Acryl, Ox 
326EDEAGEGRFNFSAYGMG 
PACLQAKDGISVK355 
Azi (3), Acryl 
334FNFSAYGMPACLQAK349 Azi 
372SPEEMRK378 
M3-M4 
Loop/M4 
Azi, Acryl 
Azi, Ox 
Azi (2), Ox 
378KLFIQ R383 
M4 
Azi 
Azi, Acryl 
Azi (3) 
384AKKIDK389 Azi (2), Acryl 
386KID KISR392 Azi (4) 
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is expected to exhibit negligible chemical activity.42,220 After photoactivation, GlyR containing 
vesicles were subjected to SDS-PAGE and GlyR containing bands were excised, trypsinized, and 
subsequently extracted peptides were analyzed by tandem MS (allowing up to 2 missed tryptic 
cleavages, as photocrosslinking at Arg or Lys sites might result in reduced trypsinolysis). For all 
studies, duplicate MS runs were conducted on samples from purified GlyR from 3 independent 
infections/preparations, and mass shifted peptides are reported with an n of > 2. Initial MS analysis 
identified precursor mass ions consistent with lipid crosslinking (cholesterol m/z shift, +386.3549 
amu) using a 10 ppm cutoff (Table 1, left column). 
  Crosslinking analysis was conducted on data sets of each of the 3 trials with peptide 
identified sequence coverage of GlyR up to 60 percent. Crosslinking analysis was not limited to a 
single cholesterol crosslinking event, but allowed up to 4 cholesterol crosslinks per tryptic peptide, 
as cholesterol is distributed in both leaflets of the lipid bilayer having the potential to interact at 
multiple sites within a single tryptic peptide (Table 1, right column, number following “Azi” 
modification), as well as “piggybacking” (cholesterol crosslinking to a GlyR bound cholesterol).  
 The identified precursor ions assigned to mass-shifted peptides containing cholesterol 
were subjected to targeted CID, and product ions were analyzed to refine the site of crosslinking 
within the mass-shifted peptide and confirm initial assignments (Table 1, bolded and underlined 
amino acid(s) within each peptide). CID fragmentation typically produces b and y product ions of 
the precursor mass ion. Through comparison of product ions (b, y, and occasionally a ions) 
containing mass shifts due to attached cholesterol to those that do not, the site of attachment can 
be refined, typically to a single amino acid site. Given that tryptic peptides could be modified at 
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more than a single site (for example, if two different amino acids on a given peptide are modified, 
these isobaric precursor ions would provide product ions after CID that obscure assignment), MS-
MS spectra are strictly matched by retention time to their precursor ion. Given that in-line liquid 
chromatography can potentially separate isobaric peptides via differential chemical properties, 
each correlated (with respect to retention time) precursor/product pair is capable of yielding a 
refined crosslinking site(s) even when present at multiple sites (sites of crosslinking within isobaric 
tryptic fragments are bolded and underlined in Table 1). By individually analyzing each product 
ion fragmentation spectrum at a given retention time, isobars may be unequivocally resolved in 
MS-MS studies. Only precursor ions assigned to cholesterol crosslinked peptides (> tetrapeptides) 
identified having overlapping sequence coverage in > 2 of 3 trials were mapped. CID 
fragmentation within the retention time window (+/- 0.2 minutes) produces product ion 
fragmentation spectra (2-12 spectra) of each cholesterol crosslinked peptide assigned precursor 
ion were individually analyzed to identify the site of covalent attachment in its respective precursor 
ion. Only product ion spectra with > 2 assigned product ions and > 2 cholesterol mass shifted 
product ions were considered, with product ion spectra typically assigning up 12 cholesterol mass 
 
Figure 9. Representative CID-induced fragmentation of crosslinked precursor ion. The identified product ion 
fragments (1-10), including those mass shifted (+ Azi), are highlighted.  
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shifted ions. A representative product ion fragmentation pattern detailing the identification of 
site(s) of covalent modification is shown in Figure 9. 
 Sites of cholesterol crosslinking following targeted MS-MS refinement were mapped to 
onto a model of α1 GlyR for visualization (Figure 10A and C), however many sites of crosslinking 
occur in the M3-M4 intracellular loop and the C-terminal tail of the receptor, regions that are not 
resolved in any pLGIC homologs and are thus missing from the homology-based model (these 
regions are discussed at greater length below and highlight the utility of CX-MS based approach 
as a complement to other biophysical methods). Refinement identified single amino acid 
crosslinking sites in succession as well as individual sites, with nearly all cholesterol crosslinks 
refined to single amino acids, and the largest identified refined site to be a tripeptide. The refined 
crosslinking sites at reduced cholesterol composition were identified in the large ECD preceding 
M1 (preceding residue 220), the M3-M4 loop (residues 309-378), and transmembrane helix M4 
(residues 379-410) of the GlyR resting state and are shown in Table 1 and Figure 10A and C. 
Within the pre-M1 ECD, crosslinking was found in regions nearing the lipid bilayer either in beta 
sheets or loops. Within the M3-M4 loop, crosslinking was identified mainly in regions nearing 
either M3 or M4 transmembrane helices. Crosslinking within M4 was identified near the 
cytoplasmic M3-M4 loop. 
 Cholesterol crosslinking sites unique to reduced cholesterol composition were observed 
(Figure 10A, light green) when compared to elevated cholesterol composition. Overall, the 
findings suggest the non-specific cholesterol:GlyR interactions to be mainly within 
extra/intracellular domains nearing or buried within the lipid bilayer and the M4 transmembrane 
helix, with these areas of GlyR expecting to have the most accessibility with the lipid interface 
 44 
 
 
 
Figure 10. GlyR-cholesterol interactions as a function of cholesterol concentration. Azi-cholesterol crosslinking at 
(A) reduced and (B) elevated cholesterol conditions mapped to a single α1 subunit of zebrafish GlyR (PDB #3JAD) 
using PyMOL v1.8.100 Areas corresponding to the bilayer are shown in gray (~15Å interfacial regions) and light 
gray (~30 Å hydrophobic acyl chain region). (A). Sites of crosslinking (bolded and underlined amino acids in Table 
1 and 2, respectively) uniquely identified at either low or high cholesterol levels are light green and those observed 
under both conditions are dark green. Beads represent regions not resolved in the zebrafish structure (M3-M4 loop 
and C-terminal tail) with crosslinks arbitrarily placed in close proximity to the lipid bilayer. Bolded beads represent 
refined sites of attachment. Space-filling GlyR pentamer (with one single subunit shown as ribbon diagram) with 
sites of crosslinking highlighted in green for  <25 mol percent cholesterol (C) and >40 mol percent cholesterol (D). 
Unresolved regions of the receptor are not shown in panels C and D. 
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given the pentameric structure, highlighting the lipid accessible regions of GlyR in its resting state 
when cholesterol exhibits negligible activity. 
2.4.2    Cholesterol crosslinking to resting state GlyR at elevated cholesterol composition  
Comparative studies and analysis analogous to those conducted with reconstituted GlyR in 
its resting state at reduced cholesterol composition were similarly conducted at elevated 
cholesterol composition of >40 mol percent. As before, GlyRs were purified from baculovirus 
infected insect cells (duplicate MS studies of 3 independent infections) and reconstituted into 
vesicles with total cholesterol enriched to >40 mol percent, but invariant levels of photoactivatable 
azi-cholesterol (6 µM). At >40 mol percent, cholesterol is expected to exhibit significantly greater 
Table 2. Cholesterol crosslinking at elevated cholesterol composition. Identified precursor ion crosslinked peptides 
at >40 percent cholesterol with conditions as described in Table 1. 
Amino Acid Sequence 
Structural  
Location 
Modifications 
17LMG RTSGYDAR27  
 
Pre-M1 
ECD 
 
Azi 
28IR P NFK33 
Azi, Acryl 
Azi (2), Acryl 
197YCTKHYNTGK206 Azi, Ox 
197YCTKHYNTGKF TCIEAR213 Azi (2), Acryl (3), Ox 
272ASLPKVSYVK281 
M2-M3 
Loop 
Azi 
Azi, Acryl 
Azi (2), Acryl (2) 
321RRHH K325 
M3-M4 
Loop 
Azi 
Azi, Ox 
Azi (2) 
323HHKEDEAGEGR333 Azi, Acryl, Ox 
372SPEE M R377 Azi, Ox 
372SPEEMRK378 M3-M4 
Loop/M4 
Azi, Acryl 
372SPEEMRKLIFQR383 Azi (3), Ox 
378KLFIQRAK385 
M4 
Azi, Acryl 
Azi (4), Acryl 
384AK K IDK389 
Azi 
Azi, Acryl (3) 
387IDKISRIGFPMAFLIFNMFYWIIYK411 Azi (4), Acryl, Ox 
415REDVHNQ421 
C-terminal 
tail 
Azi 
Azi (2), Ox 
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chemical activity,42,220 and specific interactions, as well as non-specific interactions (observed in 
trials conducted at <25 mol percent), are expected to be observed. Alternatively, different 
crosslinking sites might also be identified if higher levels of cholesterol stabilize the apo-GlyR in 
a different conformation (discussed below), thus altering the lipid accessibility profile of apo-
GlyR. After photoactivation, GlyR was similarly subjected to SDS-PAGE and the excised GlyR 
bands were trypsinized and extracted peptides were analyzed by MS-MS.  
 As before, MS analyses identified precursor ions corresponding to trypsinized peptides 
mass shifted consistent with covalent modification with cholesterol using a 10 ppm cutoff (Table 
2, an expanded Table is provided in Supplemental Material). Mass shifted precursor ions were 
targeted for CID and product ions analyzed to further refine the site(s) of crosslinking. Targeted 
MS-MS analysis identified product ion fragments including those containing cholesterol 
crosslinks, allowing for the identification of crosslinking to single amino acids (Table 2) and these 
were mapped onto a model of α1 GlyR (Figure 10B and D). The refined cholesterol crosslinking 
sites were found in the large ECD preceding M1, the M2-M3 loop, the M3-M4 loop, 
transmembrane helix M4, and the extracellular C-terminal tail (Table 2 and Figure 10B and D). 
Within the pre-M1 ECD, crosslinking was identified in regions of beta sheets and loops. Within 
the M3-M4 loop, crosslinking was identified in regions near both M3 and M4 transmembrane 
helices, primarily M3. At elevated cholesterol concentrations of >40 mol percent, crosslinking 
emerged in the M2-M3 loop and post M4 C-terminal tail compared to cholesterol crosslinking in 
reduced cholesterol conditions (<25 mol percent). Cholesterol crosslinking sites unique to elevated 
cholesterol lipid composition were observed (Figure 10B, light green) when compared to reduced 
cholesterol lipid composition. Unique crosslinking sites may be due to specific cholesterol:GlyR 
interaction sites in active cholesterol conditions, and these regions were identified in the pre-M1 
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ECD in beta sheets and unstructured loops, the M2-M3 loop, regions of the M3-M4 loop, M4, and 
the post M4 C-terminal tail. Taken together, elevated cholesterol studies revealed not only 
redundant crosslinking observed in low cholesterol studies, but additional unique crosslinking 
unique to studies conducted at elevated cholesterol content. Emergence of unique crosslinking to 
elevated cholesterol conditions, but only partial redundancy as compared to reduced cholesterol 
conditions suggests that subtle structural conformational changes occur as a function of cholesterol 
concentration (discussed at more length below).  
 This CX-MS study highlights the power of MS to sensitively and directly identify the 
cholesterol:GlyR sites of interaction in reconstituted bilayers with minute quantities of protein. 
These photocrosslinking studies directly identify covalent linkages between cholesterol and GlyR 
 
Figure 11. Comparison of predicted and experimentally determined sites of GlyR-cholesterol interaction. CRAC 
(red) and CARC (dark pink) motifs and experimentally determined crosslink sites (green) under reduced (A) or 
elevated (B) cholesterol composition are mapped to a single α1 subunit of zebrafish GlyR.100 Overlap between 
predicted and experimental sites are shown in yellow (see arrows). No CARC or CRAC motifs are found in the 
M3-M4 loop and C-terminal tail (not shown). 
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as a function of cholesterol concentration. An assumption in the study is the functional and 
chemical equivalence of azi-cholesterol and cholesterol, as validated in other published studies 
using this crosslinker.86,222–224 Given their nearly equivalent structure, it is reasonable that azi-
cholesterol and cholesterol interact with surrounding lipid and protein in a similar manner, and that 
these two lipids share identical chemical activities that vary as a function of their aggregate 
concentration. All studies were conducted at room temperature, consistent with conditions used in 
determining cholesterol activity as a function of its concentration,40 as well as the temperature 
typically used in whole cell patch clamping conditions used to correlate structure and function. 
However, it should be noted that these studies were conducted at non-physiological temperatures, 
and this may affect some of the observed interactions.   
 Elucidating the lipid-protein interface of ion channels is essential as it is a major site for 
interactions of general anesthetics with pLGICs,225,226 synthetic neurosteroids of homomeric ɑ1 
GlyR,227 and tetrahydrocannabinol with GlyR.111 All of these lipophilic compounds partition 
within the bilayer and bind and modulate pLGIC activity,85,86 but high resolution structural 
determination of membrane proteins typically require the presence of detergents and disruption of 
the bilayer. Herein we show the capability of CX-MS to directly interrogate protein-lipid 
interactions and define dozens of sites of cholesterol’s interactions with apo-GlyR in reconstituted 
vesicles of defined lipid composition. Thus, this complementary analytical tool is shown to 
sensitively map the lipid-protein interface as a function of lipid composition, allowing us to better 
map the lipid interactome with membrane proteins.  In addition, some of the sites of these 
interactions are located in other poorly resolved regions of current models of pLGICs.  
 Amino acid consensus motifs predictive of cholesterol binding have been identified where 
CRAC motifs have the sequence (L/V)-(X1-5)-(Y)-(X1-5)-(R/K) and inverted CRAC (CARC) 
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motifs have the sequence (R/K)-(X1-5)-(Y/F)-(X1-5)-(L/V) where X is any amino acid.17 CRAC and 
CARC motifs were mapped to a single subunit cryo-EM zebrafish α1 GlyR100 and compared with 
the crosslinking data (Figure 11). Cholesterol crosslinked regions of GlyR coincided to CARC 
motifs at locations within the ECD preceding and at the beginning of M1 and within M4. However, 
many of the binding sites observed at reduced and elevated cholesterol composition were not in 
the predicted regions. Conversely, some of the predicted binding sites were not observed 
experimentally. Taken together, this suggests that although the predictive CRAC/CARC motifs 
have utility, more data is necessary to ensure the motifs are more selective to accurately identify 
sites of cholesterol interactions. Investigators continue to computationally model specific sites of 
interaction of cholesterol with membrane proteins given the physiological significance of these 
interactions.224,228 
 Of note, many of the regions observed in our crosslinking data are in the large intracellular 
M3-M4 loop and the post-M4 C-terminal tail, regions of the receptor that are not resolved in any 
crystal or cryo-EM structures of pLGICs.75,218 In particular, crosslinking within the M3-M4 loop 
was often observed to charged residues of this large intracellular loop, predominately arginine, 
lysine, histidine, and glutamate. Significantly, arginine and lysine are identified in CARC and 
CRAC recognition sites for cholesterol binding. Evidence of lipid-accessible residues within 
regions whose structure is unresolved by other biophysical methods highlights the potential of CX-
MS to complement other high-resolution biophysical studies and provide a wealth of unique data. 
Cholesterol crosslinks in both the M3-M4 loop and post-M4 C-terminal tail suggest that these 
regions are in close proximity with the membrane surface. Additionally, these events may be due 
to the fluidity of the bilayer and/or protein dynamics allowing GlyR to sample different depths 
within the bilayer, bringing parts of the ECD in close proximity to the membrane surface. A striking 
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example of conformational flexibility of ion channels is evidenced in recent cryo-EM studies of 
NMDA receptors,229 where dramatic movements of the large ECD of these receptors were 
observed in a single, antagonist bound state. This large allosteric complex exhibited multiple 
conformations within a single allosteric state, with regions in the ECD appearing to be intimately 
associated with the bilayer. Site-directed spin-labeling studies have also large conformational 
exchanges to be present in regions of membrane proteins in native bilayers that are not observed 
in well-ordered crystallographic studies.230 The sensitivity of CX-MS to capture conformational 
heterogeneity via covalent crosslinking is yet another tool that may assist in identifying dynamic 
intimate associations between regions of membrane proteins. One potential limitation to CX-MS 
is the inability to easily determine the relative frequency of these events, as quantification of the 
relative abundance of crosslinks is difficult, and will be further discussed below. 
 The M4 region of pLGICs face the periphery of the receptor and have been shown to be 
lipid accessible,195 so it was anticipated that CX-MS studies would identify amino acids within 
this region under low and high cholesterol conditions. Multiple crosslinking sites at the 
intracellular end of M4 were reproducibly identified in both cholesterol conditions, with unique 
crosslinking of R383 at low conditions and K386 at high conditions, suggesting a subtle rotation of 
M4 as a function of cholesterol content. Thus, our results are consistent with nAChR studies231 
that posits conformationally distinct resting states under low and elevated cholesterol content. As 
expected, M4 sites were identified in CX-MS studies, however, cholesterol crosslinking in both 
reduced and elevated cholesterol composition were also identified in other regions of the receptor, 
including the ECD preceding M1 and the M3-M4 loop (Figure 10). Given the high solubility of 
cholesterol in DOPC bilayers (67 mol%),232 its strong partition coefficient for octanol over water 
(logPoct/wat is 7.39) and its essential insolubility in water (~2.6 x 10-5 mg/ml),233 it is assumed that 
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all cholesterol is sequestered within the bilayer. In addition to crosslinks within M4, covalently 
modified sites were reproducibly identified in regions expected to be far from the bilayer (e.g., 
60VNIFLRQQWNDPR72 and 17LMGRTSGYDARIRPNFK33 (residues in bold identify sites of 
covalent modifications within the mass-shifted tryptic peptide) in reduced and elevated cholesterol 
composition, respectively). While it is difficult to accommodate bilayer cholesterol interacting 
directly with some of the regions that appear to be far away from the membrane in the ECD (Figure 
9), the reproducibility of distinct binding sites as a function of cholesterol concentration is 
observed in our studies and this reproducibility is considered evidence that these are not random 
events due to misfolded protein and/or cholesterol in the aqueous phase. Rather, these sites, that 
also contain CARC and CRAC motifs, are postulated as being a hydrophobic cavity that may 
sequester cholesterol introduced in the mixed micelles during purification. Isoflurane and 
ketamine, general anesthetics, bind to homologous regions of the ECD of nAChR234 and GLIC,146 
consistent with the presence of conserved hydrophobic binding pockets in the ECD of pLGICs 
located distantly from the bilayer. 
 Under elevated cholesterol conditions (>40 mol percent), cholesterol crosslinking 
locations were refined to many of the same regions as observed in comparative studies at reduced 
cholesterol levels, but additionally included unique sites in the ECD, the M2-M3 loop, and the 
post-M4 C-terminal tail of the receptor. As described previously, at membrane concentrations 
below ~33 mol percent, cholesterol exhibits negligible chemical activity due to its affinity to form 
complexes with phospholipids).42,220 We propose that cholesterol crosslinks identified uniquely at 
high cholesterol levels may be due to specific cholesterol binding sites in the receptor or changes 
in lipid accessibility if the receptor adopts a different conformation at elevated cholesterol levels. 
Within the ECD preceding M1, extensive labeling of specific cholesterol crosslinked residues were 
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refined to 25DARIRPNFK33 and 202YNTGKFTCIEAR213, the latter of which precedes the M1 
transmembrane helix and might be expected to be located near the interfacial region of the lipid 
headgroups. Residues 272ASLPKVSYV280 of the M2-M3 loop were specifically crosslinked only 
at elevated cholesterol conditions, a region of the protein that is flanked by a neighboring subunit, 
suggesting non-annular interactions. This region is believed to be critical in allosterically linking 
ligand binding events with channel gating. With the post-M4 C-terminal tail, a region not resolved 
in any pLGICs,218 extensive labeling was only observed at elevated [cholesterol] at residues 
415REDVHNQ421, suggesting an intimate association with the bilayer surface at these levels.   
 Cholesterol crosslinks identified under conditions where cholesterol is expected to have 
low chemical activity are assumed to identify non-specific sites of lipid-accessibility to GlyR. As 
described in the previous paragraph, some subtle differences were observed in the labeling of M4 
as a function of cholesterol concentration. Unique crosslinking sites at lower cholesterol 
composition were also refined to the large ECD preceding M1 and the M3-M4 loop. Within the 
ECD preceding M1, exclusive labeling was refined to 60VNIFLRQQWNDPR72 and 
191EEKDLRYCTK200, the former being a region flanked by a neighboring subunit with some lipid 
accessibility while the later is directly exposed at the protein:lipid interface of GlyR. Within the 
intracellular M3-M4 loop, a poorly resolved region in structural determinations of all pLGICs to 
date, cholesterol crosslinking is uniquely observed to 349KDGISVK355, suggesting this region is 
intimately associated with the membrane surface only at lower cholesterol concentrations. For 
visualization, unique crosslinking sites observed in both reduced and elevated cholesterol 
compositions were mapped to a single subunit of a single subunit cryo-EM zebrafish α1 GlyR100 
(Figure 10A and B, light green regions). Given that unique crosslinking locations were also 
observed in the reduced cholesterol composition (<25 mol percent) not observed in the elevated 
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cholesterol composition (>40 mol percent), this suggests that GlyR adopts subtly different 
conformations at low and high cholesterol levels. This is consistent with observations that nAChR 
adopts an uncoupled conformation in the absence of cholesterol and anionic lipids that is distinct 
from the resting and desensitized states.231   
 A limitation of the current studies is that the relative abundance of the crosslinking events 
could not be determined as peak intensities in MS studies reflect the abundance of the mass ion, 
reporting on the relative ionization of the species, not its concentration. Accurate quantification 
would allow discrimination of high probability events from low probability events, further refining 
the specific interactions of cholesterol with GlyR. This is a common problem in MS-based 
discovery studies that confound the use of isotopically enriched standards. Future studies plan to 
incorporate a laser-induced fluorescence microfluidic platform under development to sensitively 
quantify derivatized peptides concurrent with MS-MS studies. Regardless, the methods described 
have reproducibly identified dozens of cholesterol crosslinks as a function of cholesterol 
concentration. Of note, these CX-MS studies do not require large amounts of purified receptor, as 
picomoles of protein in a single SDS-PAGE gel is sufficient to identify dozens of crosslinks. In 
addition, these studies are conducted in reconstituted lipid vesicles, in the absence of detergents, 
and can be conducted in a state-dependent manner in the presence or absence of agonists, 
antagonists, allosteric ligands with any desired lipid composition to identify changes in lipid 
accessibility upon channel gating and desensitization. 
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CHAPTER 3: STATE-DEPENDENT CHOLESTEROL-GLYR INTERACTIONS 
 
3.1    Abstract 
 PLGIC allostery is dependent on dynamic associations with its diverse environment. The 
cellular membrane’s lipid composition influences channel function with cholesterol being a key 
regulator of channel activity. Human α1 GlyR was purified from baculovirus infected insect cells 
and reconstituted in unilamellar vesicles at physiological cholesterol:lipid ratios with aliquots of 
azi-cholesterol, a photoactivatable non-specific crosslinker. The receptor in vesicles was then 
enriched in either a resting, open, or desensitized state prior to photocrosslinking. Following 
photoactivation, crosslinked cholesterol-GlyR was trypsinized and sites of direct covalent 
attachment to peptides were identified by targeted MS-MS. Dozens of state-dependent crosslinks 
were identified and differential patterns of cholesterol-GlyR crosslinks were observed in the 
extracellular region nearing the lipid bilayer, in the M4 transmembrane helix, and in the large 
intracellular M3-M4 loop. Unique crosslinks in comparative studies identify changes in lipid 
accessibility or modulation of hydrophobic cavities in GlyR as a function of receptor allostery. 
Most notably, the outward twisting of M4 and differential crosslinking within the M3-M4 loop 
provide new insight into allosteric repositioning of GlyR. More generally, this study provides an 
accurate and sensitive approach to mapping the protein-lipid interactions to discern state-
dependent structural movements of membrane proteins. 
 
3.2    Introduction 
 Protein function is modulated by dynamic interactions with other biomolecules such as 
metabolites, proteins and lipids, and the cellular membrane’s lipid composition has been 
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increasingly recognized as a major contributor in membrane protein function.235,236 The current 
model of the lipid membrane suggests a non-homogenous distribution of lipids and proteins that 
form microdomains, with the lipid composition modulating cellular processes at the protein-lipid 
interface either directly (i.e., binding) or indirectly (altering the physiochemical properties of the 
bilayer).52–54 Examples of these effects are the influence of lipid composition on the 
structure/stability of the transmembrane domain of amyloid precursor protein,58 the modulation of 
β2-adrenergic receptor dimer interface stabilization through cholesterol occupancy,62 the 
abrogation of dimer formation of the leucine transporter from cardiolipin delipidation,63 and the 
effects of cholesterol on ion channels.80,208,209 Lipids modulate agonist binding of GluCl through 
occupancy of membrane-spanning intersubunit crevices, promoting an expanded, open-like 
conformation that potentiates the receptor.75 The potency of GABAR is diminished by cholesterol 
depletion and restored through cholesterol enrichment of neurons.79 Lipids are frequently observed 
co-crystallized with membrane proteins, underlining the importance of specific protein-lipid 
interactions.65 For example, cholesterol co-crystallizes with G-protein coupled receptors,68 Na+,K+ 
ATPase,69 and the dopamine transporter,71 and phospholipid co-crystallizes with GluCl75 and 
GLIC.77  
 Many pharmaceuticals (anesthetics, barbiturates, benzodiazepines, cannabinoids, and 
alcohol) and bioactive lipids (progesterone, sphingomyelin, and ceramide) specifically target the 
pLGIC superfamily of ion channels.111,132–134 Anesthetics alter the permeability of both anion-
selective and cation-selective channels. However the molecular mechanism of channel modulation 
remains poorly understood.135 Bioactive lipids play a more diverse role, including the regulation 
of cell-surface nAChR levels,134 the inhibition of GABAR,133 and the modulation of nAChR 
desensitization.140 Intriguingly, both anesthetics and bioactive lipids partition at the lipid-protein 
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interface in cellular membranes,143,144 with the former being observed in crystal structures of 
pLGIC structural homologues.145,146 Cannabinoids such as Δ9-tetrahydrocannabinol potentiate 
GlyR activity via interactions at the protein-lipid interface.237 Screening of GlyR for cannabinoid-
like potentiating agents is an effective tool to discover novel therapeutics111 highlighting the 
importance in developing methodologies to sensitively probe protein-lipid interactions. Direct 
effect of anesthetic agents and alcohol of pLGICs provide valuable models for general allosteric 
modulation and to further develop anesthetic agents.238  
 Cholesterol and saturated lipids enrich lipid rafts forming highly ordered microdomain 
complexes distinct from the surrounding disordered lipid environment, with this highly ordered 
domain providing a mechanism for protein interactions and the regulation of cellular processes.239 
Cholesterol in molar excess of the capacity of these complexes has high fugacity, and is regarded 
as “active cholesterol”,36 as seen by an abrupt increase in sterol availability to cholesterol 
oxidase,37 perfringolysin,38 and methyl-β-cyclodextrin39 emerging at concentrations above 25-35 
mol percent.40,41 Excess cholesterol exhibits high chemical activity in a chemical phase distinct 
from that observed under negligible chemical activity42 that may potentially drive regulatory 
processes within or on the plasma membrane surface,43 either indirectly by modulating plasma 
membrane physical properties or directly as a protein regulator.20 Cholesterol and anionic 
phospholipids modulate nAChR allosteric transitions whereby cholesterol enrichment of 
cholesterol-depleted membranes up to a given threshold (~35 mol%) enhanced receptor-mediated 
ion flux from inactive channels to being able to undergo agonist-induced state transitions.82–86 This 
profound regulatory effect of cholesterol also causes nAChR to adopt distinct conformations as a 
function of cholesterol concentration, where in the absence of cholesterol or anionic phospholipids 
adopting a conformation that has properties distinct of the resting or desensitized state in which 
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the allosteric coupling between neurotransmitter binding sites and the transmembrane pore is 
lost.87,88 Similarly, CX-MS studies identified differential GlyR-cholesterol crosslinking patterns at 
low and high cholesterol concentrations, suggesting that GlyR adopted distinct conformations as 
a function of cholesterol concentration.178 
 The transient nature of neuronal receptor allostery typically poses a challenge for 
experimental characterization, however the approach of using photocrosslinking provides an 
opportunity to probe the dynamics of receptor gating and desensitization.179,180 Photoaffinity 
labeling studies identified the propofol-binding site of GLIC190 and GABAR191 as well as 
cholesterol interactions with the PBR,192 nAChR,194,195 and GlyR.178 The incorporation of sensitive 
MS-based approaches to sensitively identify sites of photocrosslinking has the potential to identify 
allosteric dynamics of protein structure in membranes and to examine the role of lipids in receptor 
allostery.178,179 Current tandem MS instruments have the mass accuracy and sensitivity to 
unambiguously identify and refine crosslinked species to amino acid residue(s) within a given 
peptide.178,183,184 CX-MS studies provide a valuable adjunct to crystallography and cryo-EM 
studies particularly in less resolved regions of images by providing amino acid proximity and 
distance constraint information useful in homology or de novo modeling.240 Data provided by 
state-dependent CX-MS can supplement assays elucidating channel mechanisms of 
activation/desensitization241 and allosteric coupling of domains242 by providing dynamic localized 
information regarding structural changes often in unresolved regions of proteins. 
 Given the essential, yet poorly characterized structural effects of cholesterol modulation 
of pLGICs, we examined cholesterol accessibility of GlyR at physiological levels, >40 mol% 
(above its activity threshold), in a state-dependent manner. This study focuses on comparative 
cholesterol-GlyR interactions, i.e. comparing differential azi-cholesterol crosslinking under 
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elevated “active” cholesterol conditions of the resting, open (F207A/A288G, 30 nM 
ivermectin),205 and desensitized state (10 mM glycine) using photocrosslinking coupled with 
multidimensional MS. The F207A/A288G double mutant GlyR produces an ivermectin-sensitive 
channel unable to desensitize.205 These studies expand upon a previous study178 that contrasted 
azi-cholesterol crosslinking to the resting state of 1 GlyR under low and high cholesterol levels. 
GlyR in the presence of saturating concentrations of glycine activate and stabilize channels 
predominantly in a higher-affinity ligand-bound conformation, with potential sampling of other 
states. F207A/A288G GlyR in the presence of nanomolar concentrations of ivermectin has been 
shown to stabilize channels in a conducting conformation that does not desensitize.205 Azi-
cholesterol, a photoactivatable cholesterol analog, was crosslinked to human homomeric α1 GlyR 
(wild-type and F207A/A288G) at conditions that probe interactions when cholesterol is chemically 
active (>40 mol percent natural cholesterol in membrane) in a state-dependent manner.42,220 This 
study shows that photocrosslinking coupled with tandem MS can map a lipid-protein interface in 
several allosteric states/conformations, depicting lipid accessibility during transient structural 
changes. Direct cholesterol-GlyR interactions have been identified in different allosteric 
conformations that can help refine GlyR crystallographic/cryo-electron microscopic models, 
principally in unresolved regions, provide insight into ion channel dynamics of gating and 
desensitization. 
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3.3    Materials and Methods 
 
3.3.1    Purification of GlyR from Sf9 insect cells into mixed detergent micelles 
 Purified GlyR in mixed detergent/lipid micelles were isolated as previously described.121 
Briefly, WT human α1 GlyR was overexpressed in a baculovirus infected Sf9 insect cells. Three 
days post-infection Sf9 insect cells were gently pelleted, washed with phosphate buffered saline 
(137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4), and resuspended in 
a hypotonic solution (5 mM Tris pH 8.0, 5 mM EDTA, 5 mM EGTA, 10 mM DTT). An anti-
proteolytic cocktail (1.6 µunits/mL aprotinin, 100 µM phenylmethanesulfonyl fluoride, 1 mM 
benzamidine, 100 µM benzethonium chloride) was added to reduce protein degradation 
immediately preceding lysis. Cells were lysed by sonication followed by centrifugation (387,000 
x g for 30 min) to isolate cell membranes containing GlyR. Cell membranes were washed with a 
resuspension buffer (hypotonic solution above with 300 µM NaCl) followed by centrifugation 
again to remove peripheral membrane proteins. The protein pellet was solubilized in 10:1 
digitonin:deoxycholate buffer (12 mM mixed lipids (9:1 plant extract (~95% phosphatidycholine 
purity, Avanti): egg extract (~60% phosphatidycholine purity, Avanti) at 1.5 mg/mL, stored as 
suspended vesicles), 0.10 % deoxycholate, 1.0 % digitonin, 25 mM potassium phosphate (KPi, pH 
7.4), 1 M KCl, 5 mM EDTA, 5 mM EGTA, 10 mM DTT, anti-proteolytic cocktail) overnight, and 
solubilized micelles were isolated after centrifugation (387,000 x g for 1 hr). GlyR/lipid/detergent 
micelles were affinity purified on 2-aminostrychnine agarose and eluted competitively with the 
addition of excess glycine (2M for WT preps) or strychnine-sulfate pentahydrate (1.5 mM for 
F207A/A288G preps) to the solubilization buffer. 
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3.3.2    Reconstitution of GlyR into lipid vesicles incorporating azi-cholesterol 
 GlyR vesicle reconstitution was completed as previously described124 with the following 
modifications to the lipid composition. All steps were conducted in the dark and at 5˚C unless 
noted. Mixed lipids (9:1 plant extract (95% phosphatidycholine purity): egg extract (60% 
phosphatidycholine purity) at 15 mg/mL, stored as suspended vesicles) were added to purified 
GlyR/lipid/detergent micelles to yield a final concentration of 1.5 mg/mL. Cholesterol (15.07 mM 
in methanol) with 6 µM azi-cholesterol was included to yield >40 mol percent. As previously 
described, samples were added to dialysis cassette (3500 MW cutoff, Thermo) for dialysis against 
excess 6.25 mM KPi buffer at pH 7.4. The final reconstituted protein pellet was dissolved in 25 
mM KPi buffer at pH 7.4. GlyR concentrations were quantitated using a modified Lowry assay.221  
 
3.3.3    Photo-crosslinking of azi-cholesterol to GlyR and separation of crosslinked GlyR 
 Reconstituted GlyR vesicles were placed into quartz cuvettes on ice to maintain 
temperature. Photocrosslinking of azi-cholesterol to GlyR was completed as previously 
described178 with the following modifications. To enrich for GlyR in the open state, 30 nM 
ivermectin was added to reconstituted GlyR vesicles (F207A/A288G) immediately before UV 
light exposure. To enrich for GlyR in the desensitized state, 10 mM glycine was added to 
reconstituted GlyR (WT) vesicles immediately before UV light exposure. Cuvettes were exposed 
to a 420 W Hg Arc lamp (Newport, Model 97435-1000-1, 260-320 nm) for 4 sessions of 5 minutes 
at 7 cm, with 5 minute periods of no exposure in between each UV exposure session to prevent 
sample warming. SDS-PAGE (11 % resolving, 5 % stacking) separated the crosslinked oligomeric 
and monomeric GlyR from lipids, with gel plugs excised between migration distances of 250 kDa 
and 37 kDa, encompassing the mass of oligomeric and monomeric forms of GlyR.  
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3.3.4    In-gel Trypsin digestion of crosslinked GlyR 
 Gel plugs were washed with 50:50 methanol: 50 mM ammonium bicarbonate twice for 
40 min with gentle agitation (VWR Thermal Shake Touch, 900 rpm). Gel plugs were dehydrated 
by adding 500 L acetonitrile. Once gel plugs turned whitish, acetonitrile was removed and gel 
plugs were dried in an Eppendorf 5301 Vacufuge Concentrator for approximately 15 minutes. 
Trypsin solution (10 L at 20 g/mL in 50 mM ammonium bicarbonate) was added to gel plugs 
and incubated on ice for 15 minutes, then incubated overnight at 37˚C with gentle agitation (VWR 
Thermal Shake Touch, 900 rpm). Digested peptides extracted into supernatant and transferred to 
VWR non-stick microcentrifuge tubes. Tryptic fragments were further extracted by incubating gel 
plugs twice for 30 minutes in 300 L of 0.1 % formic acid in 50:50 acetonitrile:H2O. The 
supernatant was collected and combined with initial supernatant. Tryptic extract solution was dried 
in an Eppendorf 5301 Vacufuge Concentrator. 
 
3.3.5    Mass fingerprinting of crosslinked cholesterol to GlyR  
 50:50 Acetonitrile: H2O with 0.1 % Formic Acid (50 L) was added to tubes containing 
dried tryptic extracts. ESI-Q-TOF-MS measurements were taken using an Agilent 6530 Q-TOF-
MS with an Agilent HPLC-Chip II G4240-62006 ProtID-Chip-150, comprised of a 40 nL 
enrichment column and a 75 µm x 150 mm separation column packed with Zorbax 300SB-C18 5 
µm material. The mass spectrometer was run on positive ion mode using internal standards 
(1221.9906 and 299.2944) for calibration, supplied by Agilent. Mobile phase compositions used 
were solvent A (95 % H2O, 5 % ACN, 0.1 % formic acid) and solvent B (95 % ACN, 5 % H2O, 
0.1 % formic acid) The nanoflow elution gradient was developed as follows at 0.50 µl/min of 
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solvent A (minute: percent A): 0.00: 95 %, 4.00: 10 %, 6.00: 70 %, 9.00: 50 %, 11.50: 95 %, 13.00: 
95 %. Data were processed using Agilent Qualitative Analysis Software 6.0. Cholesterol 
crosslinked peptides within a 10 ppm accuracy window were identified, accounting for possible 
peptide modifications (oxidation, acrylamidation).  
 For MS-MS studies, crosslinked samples were run again on the Agilent 6530 Q-TOF-MS, 
targeting the specific m/z ratio, charge, and retention time (RT) of the crosslinked peptides  
identified in MS analysis. CID was used for MS-MS fragmentation following a linear increase in 
collision energy by m/z using the equation: y=3.7x+2.5 (y= m/z, x= collision energy). CID was 
performed at + 0.2 min from initial MS scan RT of each crosslinked precursor ion identified. Data 
were processed using Agilent Qualitative Analysis Software 6.0 in conjunction with 
ProteinProspector v5.14.3 available through the University of California, San Francisco.  
 
3.4    Results 
 Our previous study178 identified apo state azi-cholesterol-1 GlyR crosslinking as a 
function of cholesterol concentration where differential crosslinking patterns were observed 
between cholesterol conditions of negligible chemical activity and chemically active, suggesting 
two distinct structural conformations of apo-state GlyR as a function of cholesterol concentration. 
The dependence of pLGIC activity on cholesterol has been long established and these studies were 
consistent with FTIR studies demonstrating the uncoupling of ligand binding from pore opening 
as a consequence of decreased cholesterol content.231 Given the requirement for GlyR activity on 
more elevated cholesterol concentrations, all of our comparative studies of homopentameric 
human 1 GlyR examining cholesterol crosslinking as a function of receptor allostery were 
conducted at the higher cholesterol concentrations consistent with physiological conditions.  
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 In our previous studies,178 azi-cholesterol crosslinking was observed in pre-M1 
extracellular domain on the outer lipid-exposed surface, the extracellular M2-M3 loop, regions of 
the large intracellular M3-M4 loop, the M4 transmembrane helix, and the post-M4 c-terminal tail 
(Table 2). In this study we extend these studies to examine cholesterol photocrosslinking in a state-
dependent manner, conducting comparative crosslinking studies on purified and reconstituted 
human 1 GlyR enriched in either its resting, open or desensitized states. Ivermectin promotes 
predominant stabilization of channels in a conducting conformation (open state) in F207A/A288G 
a1 GlyR.205 In our hands, F207A/A288G GlyR expressed in insect cells were gated by ivermectin 
in whole cell patch clamp studies and showed no evidence of desensitization (Tomcho et al., 
Table 3. Identified open state precursor/product ion crosslinked peptides at >40 percent cholesterol with conditions 
as described in Table 2. 
Amino Acid Sequence 
Structural  
Location 
Modifications 
17LMG RTSGYDAR27  
 
Pre-M1 
ECD 
 
Azi 
28IR P NFK33 
Azi, Acryl 
Azi (2), Acryl 
197YCTKHYNTGK206 Azi, Ox 
197YCTKHYNTGKF TCIEAR213 Azi (2), Acryl (3), Ox 
272ASLPKVSYVK281 M2-M3 Loop 
Azi 
Azi, Acryl 
Azi (2), Acryl (2) 
321RRHH K325 
M3-M4 Loop 
Azi 
Azi, Ox 
Azi (2) 
323HHKEDEAGEGR333 Azi, Acryl, Ox 
372SPEE M R377 Azi, Ox 
372SPEEMRK378 
M3-M4 Loop/M4 
Azi, Acryl 
372SPEEMRKLIFQR383 Azi (3), Ox 
378KLFIQRAK385 
M4 
Azi, Acryl 
Azi (4), Acryl 
384AK K IDK389 
Azi 
Azi, Acryl (3) 
387IDKISRIGFPMAFLIFNMFYWIIYK411 Azi (4), Acryl, Ox 
415REDVHNQ421 C-terminal tail 
Azi 
Azi (2), Ox 
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manuscript in preparation), consistent with published observations.205 Under excess ivermectin 
conditions (1.5 mM) these non-desensitizing channels are expected transition between open or 
resting states, and comparative CX-MS studies with apo studies should identify mass-shifted ions 
unique to each study, thus allowing identification of unique cholesterol binding sites restricted to 
each of these states (or exposed during structural transitions between the resting and open state).  
Similarly, in order to examine cholesterol accessibility in the desensitized state of the receptor, 
cholesterol interactions were examined in conditions of excess glycine enriching GlyR in a higher-
affinity ligand-bound desensitized conformation. Given that the receptor is expected to exist in 
resting, open, and (primarily) desensitized states, comparative studies are conducted to identify 
crosslinking sites uniquely observed in the presence of excess glycine and not in our resting or 
open state studies.  
 In this section we present evidence of crosslinks identified by LC-MS-MS in each of the 
three comparative studies, but defer more detailed interpretation of these data until the following 
Discussion section. In all cases, crosslinks presented were identified in at least 2 of 3 independent 
sample preparations/MS analysis pairings. Identified crosslinks from independent preparations 
were obtained from a single LC-MS and LC-MS-MS paired experiment. For LC-MS-MS analysis, 
mass errors in precursor/product ion identification were restricted to < 10 ppm/0.1 Dalton, 
respectively. Due to the presence of isobaric species (i.e., cholesterol binding at more than one 
location, such as adjacent amino acids, within a given proteolytic fragment), strict pairing of the 
retention times of product ions and their respective precursors allows multiple crosslinks to be 
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identified from isobaric precursor ions in single trials due to their respective differential retention 
times on the LC-MS-MS platform. 
 
Figure 12. State-dependent GlyR-cholesterol interactions at active cholesterol conditions. Azi-
cholesterol crosslinking at (A) open state and (B) desensitized state mapped to a single α1 
subunit of zebrafish GlyR (PDB #3JAD) using PyMOL v1.8.100  Areas corresponding to the 
bilayer are shown in gray (~15Å interfacial regions) and light gray (~30 Å hydrophobic acyl 
chain region). Sites of crosslinking in the open and desensitized (bolded and underlined amino 
acids in Table 2-3, respectively) identified are shown in green. Beads represent regions not 
resolved in the zebrafish structure (M3-M4 loop and C-terminal tail) with crosslinks arbitrarily 
placed in close proximity to the lipid bilayer. Bolded beads represent refined sites of attachment.  
 
A B
M3-M4 LoopM3-M4 Loop
C-termC-term
C loopC loop
Loop 2 Loop 2
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 In studies conducted on non-desensitizing F207A/A288G GlyR, cholesterol crosslinking 
was identified in the pre-M1 extracellular domain in regions distant of the membrane and closer 
proximity with the ECD-TMD interface, the entire span of the large intracellular M3-M4 loop, the 
lower portion of the M4 transmembrane helix, and the post-M4 C-terminal tail (Table 3), and these 
sites were visualized on a single α1 subunit of zebrafish GlyR (PDB #3JAD)(Figure 12A).100  
 Many crosslinks were found in unresolved regions of the α1 GlyR model (the M3-M4 
loop and C-terminal tail), and are depicted as colored beads. These crosslinking events suggest 
that these sites are in close proximity hydrophobic core of the lipid bilayer, suggesting an intimate 
association of large swaths of the heretofore unresolved M3-M4 linker with the periphery of the 
hydrophobic core of the bilayer (the expected depth of the diazirine moiety on azi-cholesterol 
 
Figure 13. Allosteric GlyR-cholesterol interactions at active cholesterol conditions. Side view of the space-filling 
GlyR pentamer (with one single subunit shown as ribbon diagram, PDB #3JAD100) with sites of crosslinking 
highlighted in green for the (A) resting state178, (B) open state, and (C) desensitized at  >40 mol percent cholesterol. 
Unresolved regions of the receptor are not shown in panels A-C.  
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(Figure 12). A profile side view of crosslinked regions (Figure 13B) displays these annular 
associations, yet also exposes more buried non-annular cholesterol interactions in hydrophobic 
pockets between subunits consistent with nAChR222 and GABAAR79 studies. 
In bottom-up views of the receptor (Figure 14B) crosslinking locations are localized on outer 
surface of GlyR, highlighting the expected predominant annular lipid surface accessibility. 
Cholesterol crosslinking only identified in open state studies, not in the apo-state is suggested to 
be unique cholesterol-GlyR interactions of the open state. Cholesterol crosslinking unique to the 
open state GlyR was observed in the pre-M1 extracellular domain in regions distant to (residue 
numbers 3, 10, 15-16, 52-55, 58) and nearing (residue numbers 105-106, 116, 193, 197, 201) the 
membrane, the large intracellular M3-M4 loop (residue numbers 227-231, 233, 237-241, 245-247, 
249, 334-337, 345-348, 350-352, 356-357, 359-371, 374), the M4 transmembrane helix (residue 
number 383), and the post-M4 c-terminal tail (residue number 417). 
 
Figure 14. Allosteric GlyR-cholesterol interactions at active cholesterol conditions. Bottom-up view of the space-
filling GlyR pentamer (with one single subunit shown as ribbon diagram, PDB #3JAD100) with sites of crosslinking 
highlighted in green for the (A) resting state178, (B) open state, and (C) desensitized at  >40 mol percent cholesterol. 
Unresolved regions of the receptor are not shown in panels A-C.  
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 In studies conducted on WT receptor in the presence of excess glycine, cholesterol 
crosslinking was identified in the pre-M1 extracellular domain in regions distant of the membrane 
and closer proximity with the ECD-TMD interface, three distinct regions of the large intracellular 
M3-M4 loop, the lower region of the M4 transmembrane helix, and the post-M4 C-terminal tail, 
mapped to a single α1 subunit of zebrafish GlyR (PDB #3JAD) (Table 4, Figure 12B).100 
Table 4. Identified desensitized state precursor ion crosslinked peptides at >40 percent cholesterol with conditions 
as described in Table 2. 
Amino Acid Sequence Structural Location Modifications 
1ARSATKPMSPSDFLDK16 
Pre-M1 ECD 
Azi, Acryl, Ox  
Azi, Ox  
3SA TKPMSPSDFLDKLMGRTSGYDAR27 
Azi, Acryl (2), Ox  
Azi, Ox  
Azi, Acryl (2), Ox (2)  
28IR PNFK33 Azi (2), Acryl  
105GAHFHEITTDNK116 
Azi, Ox (2)  
Azi  
Azi, Acryl, Ox  
105GAHF HEITTDNKLLR119 Azi, Acryl, Ox (2)  
191EEKDL RYCTK200 
Azi, Acryl  
Azi, Acryl (2)  
194DLRYCTK HYNTGK206 
Azi, Acryl (2), Ox  
Azi, Acryl (3), Ox  
Azi, Acryl (3)  
Azi, Acryl  
Azi, Ox  
197YCTKH YNTGKFTCIEA R213 
Azi, Acryl  
Azi (2), Acryl  
323HHKEDEAGEGRFNFSAYGMGPACLQAK349 
M3-M4 Loop 
Azi, Ox  
326EDEAGEGRFNFSAYGMGPACLQAKDGISVK355 Azi  
356GANNSNTTNPPPAPSKSPEE MR377 
Azi  
Azi, Acryl  
Azi, Ox  
379LFIQRAK385 M4 
Azi (4)  
Azi  
415REDVHNQ421 C-terminal Tail 
Azi (2)  
Azi, Ox  
Azi  
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Crosslinking was observed in unresolved M3-M4 loop and C-terminal tail of the α1 GlyR model 
(Figure 12B, M3-M4 loop and C-terminal tail, depicted as colored beads) and suggested to be 
intimately associated with the lipid membrane. Examination of the accessible surface of the 
pentamer, either by profile side view (Figure 13C) or viewed intracellularly facing outward (Figure 
14C), show sites of crosslinking on both the outer surface, annular lipid-accessible regions of GlyR 
as well as more buried non-annular regions consistent with crosslinking observed in the resting 
and open state trials. Cholesterol crosslinking uniquely observed in studies in excess glycine are 
proposed to be unique cholesterol-GlyR interactions of the desensitized state, and was identified 
in the pre-M1 extracellular domain in regions distant to (residue numbers 4-6, 11) and nearing 
(residue numbers 108-112, 119, 191-192, 194-196) the membrane, and intracellular M3-M4 loop 
(residue numbers 353-355, 373). 
 
3.5    Discussion 
 The differential cholesterol crosslinking patterns discerned in this study between 
conditions stabilizing the resting, open, and desensitized states of GlyR shows that CX-MS can 
identify unique cholesterol interactions in a state-dependent manner. This change in the pattern of 
cholesterol crosslinking between functional states details structural movements between allosteric 
conformations and define lipid-accessible hydrophobic regions of GlyR, as well as hydrophobic 
pockets in the receptor. Currently there are structures of GlyR bound to agonist/antagonist,100 
ivermectin,100,218 and analgesic potentiators,243 as well as forthcoming cryo-EM structures.241 
However, many of these structures have deletions and mutations for thermostability, are bound to 
ligand, and often lack the presence of a bilayer, providing limitations in modeling function of 
pLGICs. This discontinuity emphasizes the need for continued and improved methodologies to be 
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able to provide additional information for each allosteric state for full-length receptors in the 
presence of a lipid bilayer. State-dependent comparative CX-MS studies offer the unique capability 
of complementing other high resolution methodologies to help refine dynamic changes of 
membrane proteins under physiological conditions. Under physiological conditions, CX-MS can 
differentiate subtle structural movements throughout the majority of the protein, including regions 
absent in current structures. The synergistic utility of CX-MS with common structural techniques 
(x-ray crystallography and cryo electron microscopy) can drastically enhance the allosteric 
understanding of membrane proteins. 
 In the absence of quantification, this comparative state-dependent cholesterol-GlyR study 
is unable to distinguish high frequency from low frequency crosslinks identified. Therefore, it is 
assumed that crosslinking studies conducted in the presence of ivermectin (labeled as open state 
crosslinking) will capture crosslinks of both resting and open state channels as well as accessibility 
during state transitions as we are unable to distinguish crosslinking specific to the resting, open, 
or intermediate structures. Similarly, crosslinking studies conducted in the presence of glycine 
(labeled as desensitized state crosslinking) will capture crosslinks of the resting, open, and 
desensitized channels as well as accessibility during state transitions as we are unable to 
distinguish crosslinking specific to the resting, open, desensitized, or intermediate structures. 
Unique crosslinks identified within each three conditions tested are suggested to be distinctive 
cholesterol-GlyR interaction profiles and consist of up to ~58% of crosslinks identifies within each 
condition. 
  Sites of cholesterol crosslinking determined in CX-MS studies were visualized through 
mapping on the α1 GlyR strychnine-bound model.100 This model was selected to most closely 
resemble the apo-state conditions tested in the previous study given the three available α1 GlyR 
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models (strychnine, glycine, and glycine/ivermectin bound).100 To maintain consistency, all 
crosslinks of this CX-MS study are mapped on this single static model to enhance identification 
of regions exhibiting changes in lipid accessibility, thereby identifying movements of the receptor 
underlying gating and desensitization. Consequently the mapping shown for each allosteric state 
(open and desensitized) may not accurately represent structural-based crosslink localization 
identified for each state, however gives an approximate depiction of the crosslinked regions. Exact 
structural changes based upon state-dependent cholesterol crosslinking patterns mapped on the 
model are suggested to be a result of either cholesterol or protein relocation. Changes in 
cholesterol’s interaction location based upon lipid relocation are suggested to be from 
repositioning within hydrophobic pockets or regions of lipid accessibility. Changes in cholesterol’s 
interaction location based upon GlyR repositioning causes mapped crosslinked site(s) to differ 
from state to state, where the directional movement of cholesterol location is the opposite of GlyR 
actual repositioning.  
 Shifts of crosslinking patterns within M4 (Figure 15A-C) are proposed to be a result of 
M4 helix repositioning during gating and desensitization. Comparative CX-MS studies suggest the 
M4 helix undergoes a twisting during channel activation followed by an outward bending during 
desensitization. This proposed mechanism reflects the loss of crosslinking from the outer-most 
lipid accessible side of the M4 helix (resting state residues 378-382, 384-389, Table 2, Figure 15A) 
to more pronounced and concentrated crosslinking on the inner-most pore-facing side of M4 (open 
state residues 383-385, Figure 15B) indicating a clockwise twist (top-down view) of the M4 helix. 
Transition to desensitized state (residues 379, 384-385, Figure 15C) displays an increase in 
crosslinking lower on M4 at residues closer towards the intracellular domain signifying the 
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outward tilt or translation of the bottom portion of M4 helix. Taken together, state-dependent 
crosslinking of M4 suggests a outward twisting motion as the helix allosteric transitions which is 
consistent with general TMD movements observed between GlyR cryo structures stabilizing for 
the same allosteric states.100  Cholesterol crosslinking within the portion of M4 nearing the M3-
M4 loop (bilayer lower leaflet region) is consistent with similar studies of nAChR195 showing N-
terminal M4 cholesterol crosslinking. Our state-dependent cholesterol CX-MS study expands upon 
the lipid-channel studies by being able to not only highlight the specific crosslinking locations 
throughout the entire receptor, yet also distinguish the differential crosslinks in a state-dependent 
manner. 
  Differential crosslinking patterns were also observed in the ECD nearing the 
transmembrane domain. In initial CX-MS studies examining cholesterol crosslinking as a function 
of cholesterol content,178 cholesterol crosslinking in the upper ECD is suggested to arise from azi-
cholesterol accessibility to hydrophobic cavities during the detergent-based reconstitution process 
following purification, and these crosslinked regions corresponded to predicted cholesterol 
interaction locations. In resting state studies (Table 2, Figure 16A), the M2-M3 loop as well as the 
 
Figure 15. M4 differential cholesterol crosslinking. Comparison of state-dependent cholesterol 
crosslinking for the resting (A), open (B), and desensitized (C) conditions at > 40 mol percent 
cholesterol within the M4 helix. 
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“C loop” region of the outer β-sheet100 flanking above the characteristic Cys-loop were extensively 
labeled, suggesting the incorporation and presence of cholesterol into the upper leaflet of the 
bilayer along with a hydrophobic pocket between neighboring subunits. The crosslinked M2-M3 
loop residues adjoin a hydrophobic pocket at the ECD-TMD core244 in a region shown to harbor 
transmembrane cavities that bind cholesterol,79 anesthetics,245 and correspond to predicted 
cholesterol recognition motifs identified in proteins.178 Cholesterol crosslinking within and near 
the C Loop encompass the hydrophobic β-core conserved among pLGICs246 correlating with 
determined CRAC/CARC interaction motifs.178 This is a region of dynamic structural alterations 
during channel gating and desensitization247 as well as Zn2+ modulation.248 Comparing apo-state 
studies with conditions stabilizing the open state (Figure 16B) reveals a loss of M2-M3 loop 
crosslinking (residues 272-274, 277-278, 280, Table 2) in conjunction with a shift of crosslinking 
from exclusively outer β-sheet C Loop region to incorporate regions within the inner β-sheet 
(residues 52-55, 58, 105-106, 116) and lower “Loop 2”249 that adjoin ECD-TMD interface, 
 
Figure 16. ECD differential cholesterol crosslinking. Comparison of state-dependent 
cholesterol crosslinking for the resting (A), open (B), and desensitized (C) conditions at > 40 
mol percent cholesterol within the pre-M1 ECD region at the transmembrane interface. 
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suggesting a reorientation of the ECD during gating that either exposes the lower crosslinked 
residues identified or alters the hydrophobic cavity around/within the β-sheets. Juxtaposing 
crosslinking in conditions that stabilized an open channel with desensitization (Figure 16C) 
exposed nearly identical crosslinking with the exception of the loss of crosslinking in the lower 
Loop 2 (residues 52-55, 58), suggesting allosteric repositioning of the lower ECD- upper TMD 
interface during desensitization. Taken together, the ECD structure appears to be more similar 
between conducting and desensitized GlyRs than apo-state channels and that more dynamic 
movements are observed during channel activation in the lower ECD region where expansion from 
the central pore is noted.75,100  
 The large intracellular M3-M4 loop was profoundly crosslinked by cholesterol in all three 
allosteric states assayed with differential crosslinking patterns observed that clearly demonstrate 
its intimacy with the lipid membrane as well as structural movements. Given that the M3-M4 loop 
is often removed or is unresolved in the reported structures of pLGICs96,100,218,219 it is difficult to 
speculate detailed structural movements of the M3-M4 loop as GlyR transitions between allosteric 
states. Cholesterol crosslinking was identified in regions proximal to the M4 transmembrane helix 
in all allosteric states (Figure 12). Contrasting crosslinking patterns from apo-state to stabilized 
conducting-state studies (Figure 12A) show nearly identical patterns with the dramatic emergence 
of crosslinking within central region of the M3-M4 loop (residues 327-341, 345-352, 356-357, 
359-371) suggesting a reorientation of the M3-M4 loop during the gating process exposing 
previously lipid-inaccessible residues. Allosteric shifting from open to desensitized states 
illustrates the retention of cholesterol crosslinking at the ends (observed ubiquitously) and middle 
of the M3-M4 loop (Figure 12A-B), suggesting minimal conformational rearrangement that 
promotes less lipid accessibility. Taken together, the cholesterol crosslinking suggests three distinct 
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allosteric conformations of the M3-M4 loop most notably through the emergence of profound 
crosslinking in open and desensitized states exposing novel evidence pertaining to this elusive 
region of GlyR.  
 In a similar manner, the unresolved post-M4 C-terminal tail of GlyR absent in structural 
models100 was crosslinked by cholesterol in all three allosteric states assayed (Figures 13A-B, 
previous publication).178 The smaller size and lack of structural resolution makes it difficult to 
interpret results, however the crosslinked region of GlyR is assumed to be intimately associated 
with the lipid membrane. This area of the receptor is highly dynamic upon 
activation/desensitization and implicated in Zn2+ modulation, highlighting the potential relevance 
of the crosslinking data.248 Given the propensity GlyR to interact with intracellular proteins and be 
targeted for post-translational modification250,251 these effects may be partially due to altered 
interactions with lipids/accessibility or influenced by the lipid’s modulation of structure. 
Cholesterol crosslinking between allosteric states was nearly identical in the C-terminal tail, with 
subtle shifts in cholesterol labeling indicating no major differences (residues 415-417, 420-421). 
This suggests minimal alterations in lipid accessibility of the post-M4 c-terminal tail of GlyR. 
None the less, the crosslinking data sheds light on this unresolved portion of the receptor and may 
have relevance to further elucidate this region. 
 Taken together, cholesterol dramatically associates and intimately interacts with α1 GlyR 
in all domains, underlying its influence in membrane protein activity. Differential crosslinking 
patterns of cholesterol were observed as a function of concentration and allosteric state 
highlighting cholesterol’s role in channel allostery. In apo-state studies, cholesterol displayed 
deferring interactions as a function of cholesterol/channel activity whereby unique patterns where 
displayed corresponding to cholesterol chemical activity, suggesting two distinct apo-state GlyR 
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structures. State-dependent cholesterol interactions exhibit differential labeling in regions of GlyR 
that can suggest allosteric movements. Regions of the ECD, ECD-TMD interface, M3-M4 loop, 
and M4 suggest more drastic structural movements from apo-state to open-state conducting 
channels.  This methodology can provide specific and accurate structural information in a state 
dependent manner without potential detrimental structural alterations required for other high 
resolution structure studies.  
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CHAPTER 4: OVERVIEW AND FUTURE DIRECTION 
4.1 Summary 
 The incorporation of tandem CX-MS analyses into biochemical workflows can drastically 
expand the wealth of dynamic information gathered in a single experiment through generation of 
sensitive yet accurately reproducible distance constraints occurring in physiological relevant 
systems. Differential azi-cholesterol crosslinking patterns to GlyR were observed as a function of 
cholesterol concentrations as well as between conditions stabilizing GlyR in its resting, open, or 
desensitized states. This suggests either a change in lipid contacts with GlyR and/or GlyR 
structural alterations that change hydrophobic pocket(s). Cholesterol interactions were observed 
in the ECD, the ECD-TMD interface, the intracellular M3-M4 loop, and the M4 transmembrane 
helix. Theses studies have identified dozens of cholesterol crosslinks in each trial using picomoles 
of purified and reconstituted GlyR in varying lipid environments and allosteric conformations. The 
CX-MS approach pioneered herein can be applied and implemented into a variety of biochemical 
systems including other channels/transporters using any desired crosslinkers in varying functional 
states, under native-like conditions, to widen the breadth of understanding of allostery.  
 Currently there are structures of GlyR bound to agonist/antagonist,100 ivermectin,100,218 
and analgesic potentiators.243 However these studies have limitations modeling the highly 
allosteric function of pLGICs as they require deletions and mutations for thermostability, are 
bound to ligand, and often lack the presence of a bilayer. These limitations emphasize the need for 
continued and improved methodologies to be able to offer precise models for each allosteric state 
for full-length receptors in the presence of a physiologically-appropriate lipid bilayer. In current 
GlyR models, the large intracellular M3-M4 loop as well as the post-M4 C-terminal tail are absent. 
State-dependent comparative CX-MS studies offer the unique capability of complementing other 
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high resolution methodologies to help refine dynamic changes of membrane proteins under 
physiological conditions including the unresolved regions where other methods provide minimal, 
if any, information. CX-MS can differentiate subtle structural movements throughout the protein, 
including regions absent in current structures under physiological conditions and can drastically 
enhance the allosteric understanding of membrane proteins.  
 As described in Chapter 2, cholesterol within a bilayer displays differential chemical 
activity as a function of concentration. Chemically active cholesterol arises around and above ~33 
mol% cholesterol within the lipid bilayer. The chemical activity of cholesterol in turn, alters the 
channel activity of pLGICs, with elevated cholesterol levels increasing chemical activity, and this 
effect plateaus at ~35 mol% cholesterol. Unique cholesterol crosslinking patterns where displayed 
corresponding to cholesterol chemical activity, suggesting two distinct apo-state GlyR structures. 
 Cholesterol interactions, as evidenced by CX-MS, were observed in Chapter 3 to exhibit 
state-dependent differential labeling in regions of GlyR including the ECD, ECD-TMD interface, 
M3-M4 loop, and M4. These comparative studies highlight structural movements in this receptor 
that occur in transitions from apo state to open state to desensitized state. This change in cholesterol 
crosslinking patterns between allosteric states show structural movements between conformations 
and define lipid-accessible hydrophobic regions of GlyR. This information complements the 
limited availability of GlyR models that encompass allostery.100,243,252 Unresolved regions of 
current truncated/altered models based on structural studies conducted in non-physiological 
systems emphasizes the need for continued and improved methodologies to assist in generating 
precise models for each allosteric state. CX-MS studies can elucidate subtle structural alterations 
in a lipid-concentration and state-dependent manner throughout the entirety of the receptor 
reconstituted in native bilayers.  
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4.2 Future Studies  
 To further define the lipid accessible regions of the receptor and highlight potential specific 
binding sites for different classes of lipids, analogous CX-MS investigations can be performed 
using photoactivatable phospholipid crosslinkers. Anionic phospholipids like PA are required for 
nAChR resting state stabilization (analogous to cholesterol dependence studies) whereby 
membrane enrichment enhances receptor-mediated ion flux up to a given threshold (~12 mol%).86 
The potential for specific phospholipid-GlyR interactions necessary for function can be discerned 
in a state-dependent manner through comparison of PA and PC crosslinking at defined 
concentrations (>12 mol%). PC can map general phospholipid/lipid accessibility to channels, 
depicting general lipid bilayer interactions/accessibility which can differentiate hydrophobic 
pocket interactions potentially observed in the cholesterol crosslinking studies. PA crosslinking 
can map novel specific interactions or binding sites influencing channel activity through 
differentiation of PC interactions which are assumed to highlight general bilayer accessibility.  
In addition, in order to probe depth in the bilayer, the photoreactive diazirine motif can be 
moved to either carbons more distant or near to the glycerol backbone, providing an effective way 
to probe membrane depth and asymmetric depth-dependent lipid-protein interactions using 
phospholipid crosslinkers. Although less defined, the incorporation of photoactivatable diazirine 
motifs into sphingomyelin type lipids can map interactions to yet another class of lipids253 to probe 
specific concentration-dependent protein studies, such in the dimerization of SERT.254 This 
toolbox of crosslinkers can be utilized to map lipid-interaction profiles of other pLGIC members 
and structural homologs.  
 Given that the MS methods we describe cannot quantify crosslinking events, additional 
methodology needs to be developed to quantify crosslinking events. Such quantification will 
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enrich the information of crosslinking datasets to not only provide the exact crosslinking site 
location, but additionally determine the relative crosslinking frequency. Differentiating the 
frequency of each crosslinking event can illuminate regions of prolonged lipid:protein interactions 
(higher frequency events) contrasted against crosslinking regions representing cholesterol:GlyR 
interactions that sparsely occur (low frequency events) yet are captured by the exceptional 
sensitivity of the CX-MS methodology. The Cascio lab is developing a sensitive laser-induced 
fluorescence microfluidic device that can be used as a parallel quantification tool to quantitate 
tryptic peptdies (Davic, PhD thesis 2018). Peptides are derivatized on chip in immiscible 
microdroplets with an amine-reactive fluorophore that only emits strongly when derivatized and 
fluorescent emission is directly proportional to peptide concentration. Current studies are being 
conducted to normalize fluorescent emission obtained from varying amino acids and peptides 
(Apa, senior thesis, 2019). 
 The lipid-protein CX-MS studies will also be integrated with protein-protein CX-MS 
studies initiated by Dr. Rathna Veeramachaneni and currently being conducted by Kayce Tomcho. 
Both lipid-protein and protein-protein CX-MS studies provide complementary information to 
further elucidate GlyR structure, specifically when crosslinking of both studies are mapped to 
regions of models that may not be completely resolved in current models. The complementary 
information can validate our determinations of regions being in closer proximity or intimately 
associated with the lipid bilayer. The information obtained from both CX-MS studies supports 
crosslinking data that appears artifactual or spurious when mapped to the current models. By 
coupling the distance constraints created in the protein-protein CX-MS studies with the 
lipid/bilayer accessibility of the lipid-protein CX-MS studies, regions of current GlyR models can 
be more accurately defined, particularly in the regions absent in models. Overall, both lipid-protein 
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and protein-protein CX-MS studies allow for the probing and elucidation of GlyR in membranes 
at physiological-relevant different allosteric states which can complement crystallographic and 
cryo-microscopy studies to provide a better understanding of these allosteric molecular machines 
that are essential for cellular communication.  
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APPENDIX: NMDA RECEPTOR DIMERIZATION 
 
A.1    Overview 
 The NMDA receptor is a Ca2+-permeable ligand-gated ion channel component of 
excitatory neurotransmission within the CNS implicated in synaptic function, plasticity, learning, 
and memory.255NMDA receptors form tetrameric complex assemblies of several homologous 
subunits.256 The collaborative study wanted to discern if to regions of neighboring NMDA subunits 
are in close physical proximity. Specific amino acids from each subunit were mutated to cysteines 
to probe for intersubunit disulfide linkages.  
 
A.2    Methodology 
Gel bands were washed with 50:50 absolute methanol: 50 mM ammonium bicarbonate 
twice for 40 min with gentle agitation (VWR Thermal Shake Touch, 900 rpm). Gel bands were 
dehydrated by adding 500 L acetonitrile for 20 minutes. Acetonitrile was removed and gel bands 
were dried in an Eppendorf 5301 Vacufuge Concentrator for approximately 15 minutes. Trypsin 
solution (10 L at 20 g/mL in 50 mM ammonium bicarbonate) was added to gel bands and 
incubated on ice for 15 minutes, then incubated overnight at 37˚C with gentle agitation (VWR 
Thermal Shake Touch, 900 rpm); trypsin solution (10 L at 20 g/mL in 50 mM ammonium 
bicarbonate) was added to gel bands an hour into incubation. The pH was adjusted to ~2 (5M HCl) 
and pepsin solution (10 L at 1 mg/mL in H2O (pH~3) was added. Tubes were overnight at 37˚C 
with gentle agitation. Digested peptides extracted into supernatant and transferred to VWR non-
stick microcentrifuge tubes. Digested fragments were further extracted by incubating gel bands 
twice for 30 minutes in 500 L of 0.1 % formic acid in 50:50 acetonitrile:H2O. The supernatant 
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was collected and combined with initial supernatant. Digest extract solution was dried in an 
Eppendorf 5301 Vacufuge Concentrator. Dried extract was reconstituted in 50 L of 0.1 % formic 
acid in H2O for 30 minutes with gentle agitation. The reconstituted peptides were run through 
liquid chromatography-mass spectrometry (LCMS). Electrospray ionization quadrupole time-of-
flight mass spectrometry was done on the extracted peptides and measurements were taken using 
an Agilent 6530 Q-TOF-MS with an Agilent HPLC-Chip II G4240-62006 ProtID-Chip-150. 
Mobile phase compositions used were Solvent A (95 % H2O, 5 % ACN, 0.1 % Formic acid) and 
Solvent B (95 % ACN, 5 % H2O, 0.1 % Formic acid) The nanoflow elution gradient was developed 
as follows at 0.50 µl/min of Solvent A (minute: percent A): 0.00: 95 %, 4.00: 10 %, 6.00: 70 %, 
9.00: 50 %, 11.50: 95 %, 13.00: 95 %. The m/z range was 200-1700 m/z for MS analysis and 100-
2000 m/z for MSMS analysis. Data were processed using Agilent Qualitative Analysis Software 
6.0 using the following parameters: 2 missed enzymatic cleavages, 20 ppm precursor ion/ 0.1 Da 
product ion cutoff, and peptide modifications (oxidation and acrylamidation). For MS-MS 
analysis, the extracted peptide samples were run again on the Agilent 6530 Q-TOF-MS, targeting 
the specific mass-to-charge (m/z) ratio, charge, and retention time of the cross-linked peptides 
identified in MS analysis. CID was used for MS-MS fragmentation following a linear increase in 
collision energy by m/z using the equation: y=3.7x+2.5. CID was performed at + 0.2 min from 
initial MS scan retention time of each crosslinked precursor ion identified. Measurements were 
taken in triplicate from distinctive gel bands at molecular weights of crosslinked dimers.  
Precursor/product ion pairing identified in >2 of 3 trials of mass ions unique to crosslinked 
diheteromer gel band and not identified in controls (single subunit and enzymatic solution gel 
band) were considered.  
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A.3    Results 
 Following double enzymatic digestion of gel bands at molecular weights of the dimerized 
subunits, MS analysis identified up to seven precursor ions from both trials indicative of disulfide-
linked peptides and targeted for CID. MS-MS analysis identified product ions corresponding to 
both individual subunit peptides and the diheteromer linkage (Figure 17, representative figure of 
dataset).  
 
Figure 17. MS analysis of crosslinked diheteromer. Representative tandem MS-MS fragmentation scan of 
precursor m/z corresponding to crosslinked peptide pair produced from enzymatic double digestion. Fragmented 
a, b and y product ions (labeled 1-6) stemming from the crosslinked peptide pair precursor ion were assigned to 
product ions containing the disulfide crosslink between GluN1 and GluN2 (Diheteromer) as well as product ions 
assigned to individual GluN1 and GluN2 peptides due to CID of the disulfide linkage. 
 
